Skip to main content
eLife logoLink to eLife
. 2025 Sep 8;13:RP101717. doi: 10.7554/eLife.101717

Sld3CBD–Cdc45 structural insights into Cdc45 recruitment for CMG complex formation during DNA replication

Hao Li 1, Izumi Ishizaki 1, Koji Kato 1,2,†, Xiaomei Sun 2, Sachiko Muramatsu 3, Hiroshi Itou 3,‡, Toyoyuki Ose 1,2, Hiroyuki Araki 3,✉, Min Yao 1,2,✉
Editors: Akira Shinohara4, Volker Dötsch5
PMCID: PMC12416888  PMID: 40920075

Abstract

DNA replication requires recruitment of Cdc45 and GINS into the MCM double hexamer by initiation factors to form an active helicase, the Cdc45–MCM–GINS (CMG) complex, at the replication origins. The initiation factor Sld3 is a central regulator of Cdc45 and GINS recruitment, working with Sld7 together. However, the mechanism through which Sld3 regulates CMG complex formation remains unclear. Here, we present the structure of the Sld3 Cdc45-binding domain in complex with Cdc45 (Sld3CBD–Cdc45), showing detailed interactions and conformational changes required for binding to each other. The mutant analysis indicated that the binding between Sld3CBD and Cdc45 could be broken easily. We also revealed that Sld3CBD, GINS, and MCM bind to different sites on Cdc45 in the Sld3CBD–CMG model, indicating that after recruitment of Cdc45, Sld7–Sld3 could remain in Cdc45–MCM until CMG formation. The consistency between the particle size of Sld7–Sld3–Cdc45 and the distance between Sld3CBDs in the Cdc45–MCM dimer indicated the binding manner of the Cdc45–Sld3–[Sld7]2–Sld3–Cdc45 off/on MCM double hexamer. A DNA-binding assay of Sld3 and its complexes with single-stranded ARS1 (autonomously replicating sequence 1) fragments revealed a relationship between the dissociation of Sld7–Sld3 from CMG and the unwound single-stranded DNA. These findings help to further our understanding of the molecular basis of the regulation of CMG complex formation by Sld3.

Research organism: S. cerevisiae, K. marxianus, E. coli

Introduction

Eukaryotic chromosomal DNA replication in the cell cycle, a tightly regulated process that ensures precise gene copying, begins with the unwinding of double-stranded DNA (dsDNA) into single-stranded DNA (ssDNA), including the formation of an active helicase CMG complex (Tanaka and Araki, 2013; Costa and Diffley, 2022). In the G1 phase of the yeast cell cycle, two inactive helicase Mcm2–7 hexamer rings (Mcm2–6–4–7–3–5) are loaded onto autonomously replicating sequences (ARSs) of dsDNA to form a double hexamer (MCM DH) at the replication origin (Evrin et al., 2009; Remus et al., 2009; Ticau et al., 2017). To facilitate this loading, Cdt1 binds to the Mcm2–7 hexamer ring and stabilizes a gap formation between the Mcm2 and Mcm5, which serves as a dsDNA entry gate (Samel et al., 2014; Zhai et al., 2017; Bochman et al., 2008; Frigola et al., 2017). Next, the MCM DH on dsDNA is phosphorylated by Dbf4-dependent protein kinase (DDK, also known as Cdc7 kinase) (Figure 1—figure supplement 1A), allowing the key factor Sld3 and its partner Sld7 to recruit Cdc45 (Sld7–Sld3–Cdc45) to each MCM (Figure 1—figure supplement 1B; Tanaka et al., 2011; Heller et al., 2011; Kamimura et al., 2001; Nakajima and Masukata, 2002). Subsequently, the phosphorylation of Sld3 by cyclin-dependent kinase (CDK) regulates GINS assembly onto MCM DH with Dpb11, CDK-phosphorylated Sld2, and DNA polymerase ε to form CMG (Figure 1—figure supplement 1 C) (Dhingra et al., 2015; Choi et al., 2007; Bruck et al., 2011; Masumoto et al., 2002; Tanaka et al., 2013; Tanaka et al., 2007). Finally, the factors Sld2, Sld3, Sld7, and Dpb11 are released by elusive mechanisms from an active CMG, and bidirectional replication by translocating along the 3′ to 5′ direction of the DNA strand (Figure 1—figure supplement 1D) is facilitated (Costa et al., 2011; Szambowska et al., 2014).

As a central regulator of CMG formation in Saccharomyces cerevisiae, Sld3 functions as a bridge protein in the Sld7–Sld3–Cdc45 complex to recruit Cdc45 to DDK-phosphorylated MCM DH. This Sld3 contains three domains, each of which binds mainly to one of Sld7, Cdc45, and MCM. The N-terminal domain of Sld3 (Sld3NTD: M1–L116) binds to the N-terminal domain (M1–D130) of Sld7 (Sld7NTD) (Sld7 C-terminal domain [Sld7CTD: K168–S257] is a self-dimerization domain) (Itou et al., 2015). Following the NTD of Sld3, the middle part is a central portion, the Cdc45-binding domain (Sld3CBD: S148–K430) (Kamimura et al., 2001; Itou et al., 2014). A previous study also demonstrated that a region (L510–R530) in the Sld3 C-terminal domain (Sld3CTD: T445–T679) binds to Mcm4 and 6 (Deegan et al., 2016). CDK-dependent phosphorylation of two residues (T600 and S622) downstream of Sld3CTD initiates the binding of GINS-carrying Dpb11 to Cdc45–MCM (Tanaka et al., 2007; Zegerman and Diffley, 2007). In addition to its role as a bridge in the recruitment of Cdc45 and GINS, Sld3 binds to two single-stranded DNA fragments of ARS1 (ssARS) identified as the origin of DNA replication (ssARS1-2 and ssARS1-5), but not to the corresponding double-stranded ARS1 (dsARS) (Bruck and Kaplan, 2011). This specific Sld3–ssDNA association is not affected by CDK phosphorylation. Furthermore, the structures of the Sld7CTD dimer (PDBID:3X38) (Itou et al., 2015), Sld7NTD–Sld3NTD (PDBID:3X37) (Itou et al., 2015), Sld3CBD (PDBID:3WI3) (Itou et al., 2014), MCM DH (6F0L) (Abid Ali et al., 2017), CMG (PDBIDs:3JC5, 3JC6, 3JC7) (Yuan et al., 2016), CMG-DNA-polɛ (PDBID:7Z13) (Lewis et al., 2022), CMG-DONSON-DNA (PDBID:8Q6O) (Cvetkovic et al., 2023), and so forth, have been determined through crystallography and cryogenic electron microscopy (cryo-EM). Cdc45 belongs to the DHH superfamily of proteins defined by the conserved triad motif DHH (Asp-His-His), and contains a DHH-associated domain (DHHA1: R523–L650) at its C-terminus (Simon et al., 2016). Recent single-molecule biochemical assays have reported the stepwise recruitment of multiple Cdc45s to the MCM DH (De Jesús-Kim et al., 2021). However, how Sld3–Sld7 recruits Cdc45 onto the MCM for CMG formation to regulate the initiation of DNA replication remains unclear.

The present study aimed to understand how Sld3 recruits Cdc45 to the MCM DH with Sld7 for CMG formation through structure and particle analyses. We determined the structure of S. cerevisiae Sld3CBD–Cdc45 at 2.6 Å resolution and presented the detailed interactions between Sld3 and Cdc45, confirmed through in vitro and in vivo mutant analyses. Compared to the monomer structures, the conformation of Sld3CBD and Cdc45 in the Sld3CBD–Cdc45 complex changed significantly for binding to each other. Based on the structural similarity of Cdc45 in Sld3CBD–Cdc45 and CMG, we modelled Sld3CBD–Cdc45–MCM–dsDNA and SCMG–dsDNA (Sld3CBD–CMG–dsDNA) as a snapshot of how helicase CMG forms. The models demonstrated that Sld3CBD, MCM, and GINS bind to different sites on Cdc45, indicating that Sld7–Sld3 could remain at the Cdc45–MCM until CMG formation after GINS loading. Consistency between the particle size of Sld7–Sld3ΔC–Cdc45 (Sld3ΔC: M1–K430; truncated the C-terminal domain) as per spectroscopic analysis, and the distance of Sld3CBDs in the Cdc45–MCM dimer suggested that the ternary complex of Sld7–Sld3–Cdc45 forms a dimer off/on the MCM DH for recruiting Cdc45. Furthermore, ssDNA-binding analysis of ARS1 fragments suggested that the release of Sld3–Sld7 could be associated with ssARS1, unwound by CMG. Our findings illustrate the recruit–release function of Sld3 in CMG formation, expanding our knowledge of the initiation process of DNA replication.

Results

The overall structure of Sld3CBD and Cdc45 complex

We obtained a recombinant Sld3CBD–Cdc45 complex of S. cerevisiae and determined its crystal structure at 2.6 Å resolution using molecular replacement (Figure 1A, Figure 1—figure supplements 2A and 3). Only one complex molecule Sld3CBD–Cdc45 exists within an asymmetric unit. Similar to the monomeric Sld3CBD (PDBID: 3WI3, with 0.50 Å RMSD for 181 Cα atoms) (Itou et al., 2014), Sld3CBD (Y154–P420) in the Sld3CBD–Cdc45 complex is an α-helical structure with two disordered regions (R317–S336 and P364–A369). Interestingly, a disordered part in monomeric Sld3CBD was visualized as a C-terminal part of long bent helix α8 (F294–R316; hereafter referred to as α8CTP) (Figure 1—figure supplements 3 and 4A, Figure 1—figure supplement 5). Cdc45 (M1–L650) is an α/β structure composed of three β-sheets (anti-parallel: β1-β6-β5-β4-β2-β3, anti-parallel: β7-β8, mixed: β9-β10-β11-β13-β12) surrounded by 21 α-helices (Figure 1—figure supplement 3). Owing to the poor electron density map, the regions D106–K110, D166–K227, S306–V310, and T438–D460 on the molecular surface could not be built. In contrast to the monomeric human Cdc45 (huCdc45) and the CMG form (Cdc45 in the yeast CMG complex), the N-terminal part of the protruding long helix α7 D219–H231 was disordered in the Sld3CBD–Cdc45 complex (Figure 1—figure supplements 4B and 6).

Figure 1. Sld3CBD–Cdc45 complex structure.

(A) Structure of the Sld3CBD–Cdc45 complex. Sld3CBD and Cdc45 are colored in green and magenta, respectively. Cdc45-binding parts α8CTP and α9 are labelled and colored in cyan. The DHHA1 of Cdc45 is labelled and colored in dark magenta. (B) Binding part of Sld3CBD-Cdc45 in different viewing. Dotted squares C, D, and E mark three binding sites, corresponding to the bottom panel. (C) Binding site on the α8CTP of Sld3CBD. (C) (D) Two binding sites involving hydrophobic and hydrogen-bond interactions on the α9 of Sld3CBD, respectively. The interacting residues are depicted by sticks and labelled. The black dotted lines show hydrogen bonds.

Figure 1.

Figure 1—figure supplement 1. Formation of the Cdc45–MCM–GINS (CMG) complex after MCM double hexamer (DH) bound to the replication initiation site.

Figure 1—figure supplement 1.

(A) MCM DH binds to the replication origin and then is phosphorylated by DDK. (B) Sld3 and Sld7 recruit Cdc45 to the MCM DH complex. (C) After CDK phosphorylates Sld3, Dpb11 and Sld2 recruit GINS to MCM DH to form the active helicase CMG complex. (D) Finally, factors other than CMG (Cdc45–MCM–GINS) are dissociated, and double-stranded DNA (dsDNA) is unwound to ssDNA in preparation for initiating replication.
Figure 1—figure supplement 2. Purification of the Sld3CBD–Cdc45 and Sld7–Sld3ΔC–Cdc45 complexes.

Figure 1—figure supplement 2.

Size-exclusion chromatography (SEC) of ScSld3CBD–Cdc45 (A) and KmSld7–Sld3ΔC–Cdc45 (B). SDS-PAGE was performed to examine the purity of each sample in the SEC plots. Lane M shows the molecular weight markers labelled in kDa. At the upper left, we collected the principal peak in the SEC as Sld3CBD–Cdc45, which was used in other experiments. According to the bottom-right image, we collected the first half of the marked peak in SEC (B left) as purified Sld7–Sld3ΔC–Cdc45. A standards kit was measured using Superdex 200 16/60 column to check the elution volume shift of Sld7–Sld3ΔC–Cdc45. The molecular weight at the peak elution position of Sld7-Sld3ΔC-Cdc45 was estimated to be 429 kDa.
Figure 1—figure supplement 2—source data 1. PDF file containing original SDS-PAGE for Figure 1—figure supplement 2, indicating the relevant bands and treatments.
Figure 1—figure supplement 2—source data 2. Original files for SDS-PAGE displayed in Figure 1—figure supplement 2.
Figure 1—figure supplement 3. The topology diagram of Sld3CBD-Cdc45.

Figure 1—figure supplement 3.

The topology diagram of Sld3CBD and Cdc45 in the Sld3CBD-Cdc45 complex structure. α helix and β sheet were shown by the square and the arrow, respectively. The black line and dotted line represent the loop and disorder regions, respectively.
Figure 1—figure supplement 4. Structural Comparison of Sld3CBD and Cdc45.

Figure 1—figure supplement 4.

(A) Sld3CBD in the Sld3CBD–Cdc45 complex (left) and the isolated structure of Sld3CBD (3WI3) (right). The black circle indicates a long helix α8CTP that was only visible in the Sld3CBD–Cdc45 complex with an average B factor of 45 A2 for the main chain. (B) Cdc45 in Sld3CBD–Cdc45 (left; magenta), CMG (3JC6) (center; yellow-green), and isolated HuCdc45 structure (5DGO) (right; cyan). In Sld3CBD–Cdc45, the black circle indicates a long helix that was partly disordered. (C) Superposition of Cdc45 in Sld3CBD–Cdc45 by aligning Cdc45NTD (~K517) to Cdc45 in the Cdc45–MCM–GINS (CMG) complex and huCdc45, respectively (upper panel); colors are the same as those in (B). The black dotted circles indicate conformationally changed DHHA1 domains (magnified below the images). Significant changes in the α19 and downstream β-sheets in the DHHA1 domain are highlighted by the black arrow and circle, respectively. The parts with no significant conformational changes are colored gray, and the colors of the other parts are the same as those in (B).
Figure 1—figure supplement 5. Sequence alignment of Sld3/Treslin domain with structural elements.

Figure 1—figure supplement 5.

Sequence alignment of the Sld3/Treslin domain (Cdc45-binding domain: CBD) with structural elements from fungal Sld3 (S. cerevisiae, K. marxianus, and Ashbya gossypii) and vertebrate Treslin/Ticrr (Homo sapiens, Mus musculus, and Xenopus laevis). The sequences are as follows: Sld3_SACCE, S. cerevisiae; Sld3_KLUMA, K. marxianus; Sld3_ASHGO, Ashbya gossypii; Ticrr_HUMAN, Homo sapiens; Ticrr_MOUSE, Mus musculus; and Ticrr_XENLA, Xenopus laevis. CLUSTAL W (https://www.genome.jp/tools-bin/clustalw) was used to create an initial alignment, which was modified based on the 3D structure. Structural elements of TICRR_HUMAN were predicted using PSIPRED 4.0 (http://bioinf.cs.ucl.ac.uk/psipred/). * conserved sequence;: and. conserved change. Amino acids are marked and colored red, green, and blue. The secondary structures of Sld3CBD (in Sld3CBD–Cdc45) and predicted TICRR_HUMAN are shown above and below the alignment, respectively. Dashed lines in the secondary structure indicate disordered regions. The residue numbers for SLD3_SACCE are indicated above the alignment. The numbers in parentheses beside the sequences indicate the number of residues in each protein. The mutation sites used in this study are indicated by black arrows.
Figure 1—figure supplement 6. Sequence alignment of Cdc45s with structural elements.

Figure 1—figure supplement 6.

Sequence alignment of Cdc45s with structural elements from fungi (S. cerevisiae, K. marxianus, and Ashbya gossypii) and vertebrates (Homo sapiens, Mus musculus, and Xenopus laevis). The sequences are indicated as Cdc45_SACCE, S. cerevisiae; Cdc45_KLUMA, K. marxianus; Cdc45_ASHGO, Ashbya gossypii; Cdc45_HUMAN, Homo sapiens; Cdc45_MOUSE, Mus musculus; and Cdc45_XENLA, Xenopus laevis. CLUSTAL W (https://www.genome.jp/tools-bin/clustalw) was used to create an initial alignment, which was modified based on the 3D structure. * conserved sequence;: and. conserved change. Amino acids are marked and colored red, green, and blue. Secondary structures of Cdc45 in Sld3CBD–Cdc45 and HuCdc45 (PDBID: 5DGO) are indicated above and below the alignment, respectively. Dashed lines in the secondary structure indicate disordered regions. The residue numbers for Cdc45_SACCE are shown above the alignment. The numbers in parentheses beside the sequences indicate the number of residues in each protein. Black arrows indicate the mutation sites used in this study. A black frame shows the domain DHHA1.

Conformational changes in Sld3CBD and Cdc45 for binding to each other

Sld3CBD binds to Cdc45 in a way similar to a toothed gear (Figure 1B), with a contact surface of 1808 Å2 accounting for approximately 13.3% and 7.0% of the total surface of Sld3CBD and Cdc45, respectively. Two helices (α8 and α9) of Sld3CBD formed a plier structure and gripped the C-terminal domain DHHA1 (R523–L650) of Cdc45 through hydrophobic interactions and hydrogen bonds. The C-terminal loop (L646–L650) and the C-terminal part of α7 (E232–S242) of Cdc45 sandwiched the helix α8CTP of Sld3CBD. Compared to the isolated forms (PDBIDs: 5DGO and 6CC2 for huCdc45; Simon et al., 2016) and EhCdc45 (Kurniawan et al., 2018, respectively) and the CMG form (PDBID: 3JC6; Yuan et al., 2016), the Cdc45 in the Sld3CBD–Cdc45 complex changed the conformation of DHHA1 to form pockets on its two sides for binding Sld3CBD α8CTP and α9. The remaining part of Cdc45 (~K517) retained a structure with RMSD values of 1.29 Å (isolated huCdc45), 1.81 Å (isolated EhCdc45), and 1.295 Å (in CMG) for 243, 251, and 361 Cα atoms, respectively.

The Sld3CBD helix α8CTP (F294–R316), surrounded by the C-terminal domain DHHA1 and a C-terminal part of the protruded long helix α7 (E232–S242) of Cdc45 (Figure 1B), seems to be an intrinsically disordered segment. When Sld3 is alone, it is disordered but folds into a visualizable helix coupled to the binding partner Cdc45 in the Sld3CBD–Cdc45 complex (Figure 1—figure supplement 4A). Previous studies reported that this α8CTP is essential for binding to Cdc45, as its deletion inhibited cell growth (Itou et al., 2014). Furthermore, proline substitution for Cdc45 Ser242 (strain Cdc45-35; Kamimura et al., 2001), which interacts with L307 and T310 in Sld3CBD α8CTP (Figure 1C), conferred temperature-sensitive growth to yeast cells (Figure 2—figure supplement 1). Although an increase in the number of copies of Sld3–Sld7 could weakly suppress cell growth defects, it did not recover the disrupted interaction.

The α9 (L337–E360) of Sld3CBD is the secondary Cdc45-binding region, which is located at a shallow dent formed by the C-terminal helix and a loop with the following β-strand (K520–Q531) of Cdc45 DHHA1 (Figure 1B, D and E). Three hydrophobic residues (I352, I355, and L356) in Sld3CBD α9 interact with the C-terminal sheet (L522, L527, and V529) and helix (L641 and L647) of Cdc45 DHHA1 (Figure 1D), while the side chains of two negatively charged residues (D344 and D348) form hydrogen bonds through a water molecule to the main and side chains of R523 on a loop of Cdc45 DHHA1 (Figure 1E). A disordered region, L527–V529, of Cdc45 DHHA1 in the isolated form forms a β-sheet in the Sld3CBD–Cdc45 complex and binds to I352 and I355 of Sld3CBD α9. We substituted single, double, or triple positively charged or hydrophilic residues at D344, D348, I352, I355, and L356 of Sld3CBD α9 (D344R/D348R: Sld3-2R, I352Y: Sld3-Y, I352S/I355S/L356S: Sld3-3S, I352E/I355E/L356E: Sld3-3E). Based on the CD spectra, we confirmed that these mutants retained the structural elements of Sld3CBD (Figure 2—figure supplement 2). Double and triple mutants Sld3-2R, Sld3-3S, and Sld3-3E eliminated Cdc45-binding affinity, whereas the single mutant Sld3-Y seemed to retain a faint interaction with Cdc45 (Figure 2A). We also substituted the single, double, or triple residues R523, L522, L527, V529, L637, and L641 of Cdc45 on Sld3CBD α9 binding sites (L637S/L641S: Cdc45-IIS, L637E/L641E: Cdc45-IIE, L522S/L527S/V529S: Cdc45-IIIS, L522E/L527E/V529E: Cdc45-IIIE, and Cdc45-A: R523A). All Cdc45 mutants disrupted the binding between Sld3CBD and Cdc45, except for Cdc45-A, as surmised from the Sld3CBD–Cdc45 structure (Figure 2B). Although mutant Cdc45-A eliminated three hydrogen bonds with D344 of Sld3CBD, the remaining hydrogen-bond network maintains contact between Sld3CBD and Cdc45. Furthermore, in vivo genetic studies confirmed the importance of these Sld3 residues. Expression of Sld3-3S, Sld3-3E, and Sld3-2R in Sld3 caused no growth, while the Sld3-Y strain maintained cell growth (Figure 2C). These results demonstrate that the cooperative action of these residues is essential for Cdc45 binding, and loss of Sld3’s Cdc45-binding affinity inhibits Cdc45 recruitment and subsequent formation of active replicative helicase CMG for DNA replication.

Figure 2. Mutation analysis of interacting residues.

(A) In vitro binding analysis was checked using SDS-PAGE after Ni-affinity chromatography extraction of co-overexpressed Cdc45 with each Sld3 mutant. Sld3 was tagged by His-tag to bind to the column. The labels M, W, Y, 3E, 3S, and 2R are explained on the right. (B) In vitro binding analysis was checked using SDS-PAGE after Ni-affinity chromatography extraction of co-overexpressed Sld3 with each Cdc45 mutant. Sld3 was tagged by His-tag to bind to the column. The labels M, W, A, IIIE, IIE, IIIS, and IIS are explained on the right. (C) In vivo cell growth analysis of yeast cells carrying sld3 mutations. The yeast YYK13 cells carrying SLD3 or its mutant plasmids were streaked onto SD and FOA plates and then incubated at 298 K for 3 days. YYK13 yeast is a mutant lacking the SLD3 gene with added SLD3/sld3 mutant gene (YCplac22 plasmid containing SLD3 or sld3 mutant) that grew on SD and FOA plates. The empty plasmids were used as a negative control (NC). Mutations in Sld3-Y, Sld3-3E, Sld3-3S, and Sld3-2R are the same as those in A.

Figure 2—source data 1. PDF file containing original SDS-PAGE for Figure2, indicating the relevant bands and treatments.
Figure 2—source data 2. Original files for SDS-PAGE displayed in Figure2.

Figure 2.

Figure 2—figure supplement 1. In vivo mutation analysis of Cdc45 using mutant cells.

Figure 2—figure supplement 1.

SLD3 on the high-copy YEplac195 plasmid and SLD7 on the high-copy YEplac112 plasmid were introduced into mutant cells bearing a mutation that replaced Cdc45 Ser242 with proline on the Sld3 binding surface (Cdc45S242P). The transformants were streaked onto yeast extract–peptone–dextrose plates and individually incubated for 3 days at 25°C and 32°C. Blank plasmids YEplac195 and YEplac122 were used as negative controls (NC). CDC45 was introduced into the YEplac195 plasmid as a positive control. Cell growth was suppressed by Cdc45S242P mutation at 32°C.
Figure 2—figure supplement 2. SDS-PAGE analysis and circular dichroism spectra of Sld3 mutants.

Figure 2—figure supplement 2.

Structural elements of Sld3-3S, Sld3-3E, Sld3-2R, and Sld3-Y (Sld3-3S: I352S/I355S/L356S, Sld3-3E: I352E/I355E/L356E, Sld3-2R: D344R/D348R, and Sld3-Y: I352Y) were analyzed through circular dichroism. While the mutants of Sld3CBD existed alone, we prepared WT Sld3CBD in a complex with Cdc45 and calculated the elements of secondary structure from the crystal structure of Sld3CBD–Cdc45. All variants appeared to maintain the same structural elements as wild-type Sld3CBD–Cdc45, as indicated in the table. The concentration of samples was controlled to the same level for CD measurement.
Figure 2—figure supplement 3. Mutation analysis of Cdc45.

Figure 2—figure supplement 3.

(A) Binding site of Cdc45 to Sld3CBD, GINS, and MCM. Two Cdc45 sites involved in binding to MCM (Cdc45 G367) and GINS (Cdc45 W481) are colored in red. (B) In vitro binding analysis was checked using SDS-PAGE after Ni-affinity chromatography extraction of co-overexpressed Sld3CBD with each Cdc45 mutant. Sld3CBD with His-tag bound to the column. The labels M, W, R, and D are explained on the right.
Figure 2—figure supplement 3—source data 1. PDF file containing original SDS-PAGE for Figure 2—figure supplement 3, indicating the relevant bands and treatments.
Figure 2—figure supplement 3—source data 2. Original files for SDS-PAGE displayed in Figure 2—figure supplement 3.

In comparison with Cdc45 alone (huCdc45) or CMG form (in CMG complex), domain DHHA1 of Cdc45 changed conformation significantly for binding to Sld3CBD (Figure 1—figure supplement 4C). The loop I595–N604 in Cdc45 DHHA1 changed conformation to interact with α8CTP of Sld3CBD. Subsequently, the helix α19 (F605–E615) rotated the C-terminus by 25 degrees, which altered the conformation of the next two β-strands (β12 and β13) in the mixed β-sheet (β9-β10-β11-β13-β12) (Figure 1—figure supplements 3 and 4C), allowing Sld3CBD α8CTP to enter the binding pocket. Interestingly, the Sld3CBD-Cdc45 structure shows that the Sld3CBD binding site of Cdc45 is distinct from the binding site of Cdc45 with GINS or MCM, suggesting that the Sld3CBD, Cdc45, and GINS could bind to MCM without steric clash (Figure 2—figure supplement 3A). Furthermore, we conducted a mutation analysis on two Cdc45 residues involved in binding to MCM (Cdc45 G367D) and GINS (Cdc45 W481R) (Denkiewicz-Kruk et al., 2025), respectively, and found that these mutations did not disrupt the Sld3CBD-Cdc45 complex (Figure 2—figure supplement 3B).

Cdc45 recruitment to MCM DH by Sld3 with partner Sld7

Except for the Sld3 binding region DHHA1, the N-terminal domain of Cdc45 (Cdc45NTD) retained a structure similar to that in the monomer, Sld3CBD–Cdc45 complex, and CMG complex. Therefore, we modelled Sld3CBD–Cdc45–MCM–dsDNA and SCMG–dsDNA (Figure 3) by superposing Cdc45NTD structures between Sld3CBD–Cdc45 and each monomer of CMG dimer, which was modelled by superposing Mcm2–7 structures between CMG (PDBID: 3JC6) (Yuan et al., 2016) and MCM DH–dsDNA (PDBID: 5BK4) (Noguchi et al., 2017). In the models, two Sld3CBDs are located in each monomer of the Cdc45–MCM dimer over 230 Å apart (Figure 3A).

Figure 3. Ribbon models of complexes in dimer form and particle analysis.

(A) Sld3CBD–Cdc45–MCM–dsDNA complex. Mcm2, 5, 4, and 6 subunits are colored in cyan, blue, marine, and light blue, respectively. Subunits Mcm3 and Mcm7 are colored in gray. Green and pink are used to color Sld3CBD and Cdc45, respectively. dsDNA is represented by a dark-orange stick. (B) Sld3CBD–Sld7–Cdc45 dimer before associating with the MCM DH. Sld3 and Cdc45 are shown in the same color as they are in A, while Sld7 is colored in orange. The two phosphorylated Sld3 residues are depicted as yellow balls. Particle analysis of Sld7–Sld3ΔC–Cdc45 through dynamic light scattering is shown on the bottom panel. The average peak size of the particle size distribution of the Sld7–Sld3ΔC–Cdc45 complex was estimated to be 232 Å in diameter. The measurement was carried out independently four times (Figure 3—figure supplement 1). (C) SCMG–dsDNA complex. GINS is shown in yellow, and the remainder are colored identically to those in A and B.

Figure 3.

Figure 3—figure supplement 1. Dynamic light scattering (DLS) of Sld7–Sld3ΔC–Cdc45.

Figure 3—figure supplement 1.

Four samples of the Sld7–Sld3ΔC–Cdc45 complex were measured by DLS. Each sample was overexpressed independently and purified through size-exclusion chromatography. For data analysis, each sample was measured three times. The particle size was estimated to be 232 Å in average of peak size from four samples. The pure buffer was measured as a background control and 10 μM lysozyme was measured as a standard control, shown by orange and blue curves, respectively.
Figure 3—figure supplement 2. Size-exclusion chromatography (SEC)-small-angle X-ray scattering (SAXS) analysis of Sld7–Sld3ΔC–Cdc45.

Figure 3—figure supplement 2.

SEC-SAXS measurements of Sld7–Sld3ΔC–Cdc45 complex were performed using a beam line BL-10C at the Photon Factory (Tsukuba, Japan). SEC-SAXS data were collected under camera length 2 M, wavelength 1.5 Å, and 20℃ with a program Seral Analyzer (upper panel) (Yonezawa et al., 2019). A program SAngler was used to analyze the SEC-SAXS data (Shimizu et al., 1741). The Guinier plot (left) and Kratky plot (right) are shown in the lower panel. Rg and Dmax were estimated around 85 and 345 Å, respectively. Ascent side: the SAXS data collated from the left side of the SEC-plot peak. Peak: the SAXS data collected from a peak point of the SEC plot.
Figure 3—figure supplement 3. DHHA1 domains of Cdc45s.

Figure 3—figure supplement 3.

The DHHA1 domains of Cdc45 in the Cdc45–MCM–GINS (CMG) complex (PDB ID: 3JC6) (A) and the SCMG–double-stranded DNA (dsDNA) model (B), are shown. DHHA1s are colored in red and around the black circles. Labelled Mcm2, 5, 4, and 6 subunits are colored in cyan, blue, marine, and light blue, respectively. Subunits Mcm3 and Mcm7 are colored in gray. Green and pink were used to indicate Sld3CBD and Cdc45, respectively. GINS is shown in yellow and dsDNA is presented as a dark orange stick. The contact area between DHHA1 and Mcm2 is magnified in the bottom panel of the figure. The black dotted circles mark the contact between DHHA1 and Mcm2CTD in CMG complex (A) and SCMG–dsDNA model (B), respectively. The predicted closed residues between Cdc45 and Mcm2 in the SCMG–dsDNA model are labelled.

To investigate how Sld7–Sld3 brings Cdc45 to MCM DH, we attempted particle analysis for the Sld7–Sld3–Cdc45 complex using the purified recombinant Sld7–Sld3ΔC–Cdc45. The approximate molecular weight of Sld7–Sld3ΔC–Cdc45 was estimated to be >400 kDa according to a weight calibration of size-exclusion chromatography (Figure 1—figure supplement 2B). Given that the molecular weight calculated from its amino acid sequences was 158 kDa, the purified complex should be a dimer. Considering the Sld7–Sld3ΔC–Cdc45 dimer should be a long, rod-shaped molecule, the estimated value from SEC could be larger than the theoretical values. Subsequently, using dynamic light scattering (DLS), the particle size (hydrodynamic diameter) of the tripartite complex was estimated to be around 232 Å (Figure 3B, Figure 3—figure supplement 1), which is consistent with the distance of Sld3CBDs in the model of Sld3CBD–Cdc45–MCM dimer. To further validate the SEC and DLS results, we performed size-exclusion chromatography coupled with small-angle X-ray scattering (SEC-SAXS), which suggested a molecular weight of 370–420 kDa, and an Rg >85 Å (Figure 3—figure supplement 2). Considering that the domains of Sld7 (NTD: Sld3NTD-binding, CTD: self-dimerization) and Sld3 (NTD: Sld7NTD-binding, CBD: Cdc45-binding, CTD: MCM-binding) function independently (Itou et al., 2015; Itou et al., 2014), we estimated a dimer model of Sld7–Sld3ΔC–Cdc45, as shown in Figure 3B. Because the domains of Sld7–Sld3–Cdc45 are linked by long loops, the dimer forms a long shape with high flexibility.

Our SCMG–dsDNA model demonstrated that Sld3CBD neighbors Mcm2 and binds to Cdc45 on the opposite side of GINS binding (Figure 3C), indicating that Sld7–Sld3 bound to the Cdc45–MCM dimer does not contact GINS and could remain until CMG formation. A recent study also reported a structure of the DONSON (Sld2 homolog) dimer with CMG (8Q6O), showing that the DONSON dimer delivers GINS to MCM and reconfigures the MCM motors in the double CMG (Cvetkovic et al., 2023). The DONSON dimer is loaded at the GINS site on MCM, which is the opposite of Sld3CBD in the SCMG-dsDNA model. Interestingly, in the Sld3CBD–Cdc45–MCM–dsDNA and SCMG–dsDNA models, we found that a part (S358-D383) of Sld3CBD, containing the C-terminal of α9, a disordered fragment, and α10, was in contact distance with Mcm2CTD. In addition, the Sld3CBD-bound Cdc45 DHHA1 appeared to be close to Mcm2CTD. In contrast, the Cdc45 DHHA1 does not contact Mcm2–7 or GINS in the CMG structure (Figure 3—figure supplement 3). The conformational change in Cdc45 DHHA1 not only facilitates binding with Sld3CBD but could also lead to contact with Mcm2.

ssDNA binding affinity of Sld3 depended on complex formation with Cdc45 and Sld7

Previous studies showed that Sld3 binds directly to single-strand DNA fragments (ssARS1-2 and ssARS1-5) of ARS1 identified as an origin of DNA replication (Bruck and Kaplan, 2011). ARS1 was divided into three 80 bp segments: ARS1-12, ARS1-34, and ARS1-56. These dsDNA segments could unwind into six single-stranded DNA fragments of 80 nucleotides (nt) in length: ssARS1-1, 2, 3, 4, 5, and 6 (Figure 4—figure supplement 1A). Given that Sld3 binds to Sld7 and Cdc45 on the MCM–DNA complex during CMG formation, we investigated whether Sld7 and Cdc45 affect the ssDNA-binding affinity of Sld3. Therefore, we performed an ssDNA binding assay using the Sld3CBD, Sld3CBD–Cdc45, Sld7–Sld3ΔC–Cdc45 and Sld7–Sld3ΔC (Sld3ΔC: M1–K430, domains for binding Sld7 and Cdc45) complexes against different regions of ssARS1 for comparison. Due to limitations in protein overexpression, we utilized Sld7–Sld3ΔC–Cdc45 and Sld7–Sld3ΔC from K. marxianus (same family as S. cerevisiae). Moreover, Cdc45 exhibits higher affinity for >60 nt ssDNA compared with shorter ssDNA (Bruck and Kaplan, 2013). Therefore, we fragmented each ssARS1 into fragments of 40 nt to prevent such nonspecific binding (Figure 4A, Figure 4—figure supplement 1B).

Figure 4. Electrophoresis mobility shift assay (EMSA) of single-stranded DNA (ssDNA) binding to Sld3 and its complexes with Sld7 and Cdc45.

(A) Schematic of ssARS1-1–ssARS1-6. ARS1 is identified as an origin of DNA replication and divided into three 80 bp segments: ARS1-12, ARS1-34, and ARS1-56. These double-stranded DNA (dsDNA) segments could unwind into six single-stranded DNA fragments with 80 nt length: ssARS1-1, 2, 3, 4, 5, and 6. The important elements of A (autonomously replicating sequence, ARS consensus sequence), B1, B2, and B3 for unwinding are marked (Newlon and Theis, 1993). We divided ssARS1-2 and ssARS1-5 fragments (blue squares) into 40-base lengths for electrophoretic mobility shift assay (EMSA). (B) ssDNAs were visualized using Fast Blast DNA stain on polyacrylamide gels. In the presence of ssDNA fragments, Sld3CBD, Sld3CBD–Cdc45, Sld7–Sld3ΔC–Cdc45 and Sld7–Sld3ΔC were incubated with molecular mass-related concentrations. The molecular ratio of ssDNA to protein in lanes 1, 2, 3, 4, and 5 was 1:0, 1:0.5, 1:1, 1:2, and 0:1, respectively. The controls for ssDNA and protein are lanes 1 and 5, respectively. No binding ssDNA group (ssARS1-3_1) is shown at the bottom as a negative control (NC). The overall views of the EMSA results are shown in Figure 4—figure supplement 2. (C) The integral grayscale of the ssDNA bands was calculated and compared to the average of the ssDNA control band to determine the residual levels, showing differences in binding affinity. By three ratios, Sld3CBD-Cdc45 demonstrated a significantly ssDNA residual level (t-test, ****p<0.0001) compared to other samples, indicating low binding affinity to ssDNA.

Figure 4—source data 1. PDF file containing original native-PAGE for Figure 4, indicating the relevant bands and treatments.
Figure 4—source data 2. Original files for native-PAGE displayed in Figure 4.

Figure 4.

Figure 4—figure supplement 1. Sequence of ssARS1 fragments.

Figure 4—figure supplement 1.

(A) Fragments of ssARS1-1 through ssARS1-6 used in this study. Each ssARS1 fragment contains 80 bp. Fragments of odd and even numbers are complementary strands. The important elements A (autonomously replicating sequence, ARS consensus sequence), B1, B2, and B3 for unwinding are marked (Yuan et al., 2016). The fragments in the blue square are Sld3 binding parts of ssARS1. (B) The fragments of Sld3 binding parts (blue square parts in (A)) of ssARS1-2 and ssARS1-5. Each fragment of ssARS1-2 and ssARS1-5 is separated into 40 bp lengths: ssARS1-2-1 to ssARS1-2-3 and ssARS1-5-1 to ssARS1-5-3.
Figure 4—figure supplement 2. Electrophoresis mobility shift assay (EMSA) of ssDNA binding to Sld3 and its complexes with Sld7 and Cdc45.

Figure 4—figure supplement 2.

(A) Single-stranded DNAs (ssDNAs) were visualized using Fast Blast DNA stain on polyacrylamide gels. In the presence of ssDNA fragments, Sld3CBD, Sld3CBD–Cdc45, Sld7–Sld3ΔC–Cdc45, and Sld7–Sld3ΔC were incubated with molecular mass-related concentrations. The molecular ratio of ssDNA to protein in lanes 1, 2, 3, 4, and 5 was 1:0, 1:0.5, 1:1, 1:2, and 0:1, respectively. The controls for ssDNA and protein are lanes 1 and 5, respectively. The negative controls for no binding with ssDNA (ssARS 1–3_1, NC) of each sample are shown at the bottom. The reduce or disappearance of the ssDNA band in lanes 2–4 indicates that the protein (Sld3CBD, Sld7–Sld3ΔC, and Sld7–Sld3ΔC–Cdc45) binds to ssDNA with high affinity. The smeared bands appear in high molecular weight regions of lanes 2–4, when mixed with Sld7–Sld3ΔC–Cdc45 or Sld7–Sld3ΔC, whereas no bands appeared in the negative control (NC) (ssARS1-3_1). The positions of smeared ssDNA bonds correspond to those of protein in the protein-stain pages, indicating that ssARS1 was complexed with proteins. (B) The proteins were visualized using Coomassie brilliant blue on gels. The EMSA experiments were conducted concurrently under equivalent conditions to (A). The smeared bands in the high molecular weight parts of lanes 2–4 of Sld3CBD–Cdc45, Sld7–Sld3ΔC–Cdc45, and Sld7–Sld3ΔC are shown more clearly when mixed with ssDNA. Such enhanced discernibility indicates that these proteins easily enter the gel with ssDNA, even though Sld3CBD–Cdc45 binds ssDNA weakly. Sld3CBD could not enter the gel, even when bound to ssDNA, because the pI values exceeded the pH of the running buffer (pH = 8.3). Due to limitations in protein overexpression, we utilized Sld7–Sld3ΔC–Cdc45 and Sld7–Sld3ΔC from K. marxianus (same family as S. cerevisiae).
Figure 4—figure supplement 2—source data 1. PDF file containing original native-PAGE for Figure 4—figure supplement 2, indicating the relevant bands and treatments.
Figure 4—figure supplement 2—source data 2. Original files for native-PAGE displayed in Figure 4—figure supplement 2.
Figure 4—figure supplement 3. DNA-binding assay by electrophoresis mobility shift assay.

Figure 4—figure supplement 3.

(A) Different concentrations of Sld3CBD–Cdc45 and Sld7–Sld3ΔC–Cdc45 were incubated with ssDNA fragments. Lanes 1, 2, 3, and 4 represent ssDNA to protein ratios of 1:0, 0:1, 1:1, and 1:2, respectively. Lanes 1 and 2 are controls for single-stranded DNA (ssDNA) and protein, respectively. The DNAs were visualized using SYBR Safe on polyacrylamide gels. (B) Different concentrations of Sld7–Sld3ΔC–Cdc45 were incubated with the dsDNA fragment (dsARS1-34_1) mixed with jointed ssDNA fragments (ssARS1-2_1 or ssARS1-3_2). The ssARS1-2_1 and ssARS1-3_2 connect to dsARS1-34_1 at different sites. The control for ssDNA and double-stranded DNA (dsDNA) is located in lanes 1 and 2, respectively.
Figure 4—figure supplement 3—source data 1. PDF file containing original native-PAGE for Figure 4—figure supplement 3, indicating the relevant bands and treatments.
Figure 4—figure supplement 3—source data 2. Original files for native-PAGE displayed in Figure 4—figure supplement 3.
Figure 4—figure supplement 4. Surface charge of Sld3CBD-Cdc45 and Sld3NTD-Sld7NTD.

Figure 4—figure supplement 4.

The Sld3CBD-Cdc45 (A) and Sld3NTD-Sld7NTD (B) are presented in a charged surface calculated by the Pymol program. The blue and red show positive and negative charges, respectively. Cdc45 covers the main positive charge area of Sld3CBD α8CTP (A). A large positively charged region surrounds the middle of Sld7NTD in Sld3NTD-Sld7NTD (B).
Figure 4—figure supplement 5. Model of Sld3CTD on the Cdc45–MCM–GINS (CMG).

Figure 4—figure supplement 5.

(A) Sld3CTD diagram on the SCM complex model. Sld3 could extend the C-terminal domain to interact with the Mcm4 NTD via the NTDs of Mcm2 and Mcm6. (B) Expansion of the Sld3CTD in close-up. The black dotted region denotes the extended region of Sld3CTD, which binds to the NTDs of Mcm2, Mcm4, and Mcm6. Sld3CBD C-terminal P420 is shown as red spheres. Labelled Mcm2, 4, and 6 subunits are colored cyan, blue, and purple blue, respectively. The subunit Mcm5 is colored dark blue, and the subunits Mcm3 and Mcm7 are colored gray. Green and pink are used to color Sld3CBD and Cdc45, respectively. GINS is shown in yellow, and a dsDNA is presented by the stick with dark orange.

To investigate the specificity of the ssDNA binding affinity of Sld3, we employed an electrophoretic mobility shift assay (EMSA) using non-denaturing PAGE (native-PAGE) with ssDNAs or proteins alone as controls (Figure 4B, Figure 4—figure supplement 2). Additionally, an ssDNA (ssARS1-3_1) with no binding affinity to protein samples was used as a negative control (NC), where no ssDNA band disappeared and no new ssDNA band appeared. For the Sld3CBD and ssDNA mixtures at a molar ratio of 1:1, the band corresponding to ssDNA disappeared, indicating a binding affinity between Sld3CBD and ssDNA (Figure 4C). The ssDNA band remained when the Sld3CBD–Cdc45 complex was mixed with ssDNA at the same ratio, indicating that the binding affinity of Sld3CBD–Cdc45 for ssDNA was lower than that of Sld3CBD alone (Figure 4C). Additionally, the decrease of ssDNA bands correlated with an increase in the concentration of Sld3CBD–Cdc45 in the mixture.

In the presence of the Sld7–Sld3ΔC–Cdc45 complex, the band corresponding to ssDNA disappeared under the equimolar ratio of protein and ssDNA, similar to that observed for Sld3CBD. In this case, smeared bands appeared in the high molecular weight part of ssDNA-staining PAGE (Figure 4B, Figure 4—figure supplement 2). The positions of smeared ssDNA bands correspond to those of protein in the protein-stain pages, indicating that ssARS1 were complexed with proteins. This result demonstrates that the presence of Sld7 and Sld3NTD could increase the ssDNA-binding affinity to a level comparable to that of Sld3CBD. Also, Sld7–Sld3ΔC showed the ssDNA-binding affinity similar to that of Sld7–Sld3ΔC–Cdc45, implying that the ssDNA-binding of Sld7–Sld3ΔC is independent of Cdc45. Furthermore, the results revealed no significant difference in binding affinity between the 40-base fragments of ssARS1-2-1, 2, 3 and ssARS1-5-1, 2, 3 for Sld3CBD, Sld3CBD–Cdc45, Sld7–Sld3ΔC–Cdc45, and Sld7–Sld3ΔC, indicating that there is no stronger binding-region specific to ssARS1-2 or ssARS1-5 fragments. For sequence specificity, we also analyzed other fragments (ssARS1-1, 3, 4, and 6, and dsARS1), and all of them showed no binding (Figure 4—figure supplement 3).

The surface charge of the Sld3CBD–Cdc45 structure shows that Cdc45 covers the main positive charge region of Sld3CBD α8CTP (Figure 4—figure supplement 4A), which may weaken the binding affinity of Sld3CBD–Cdc45 to ssDNA. Conversely, on the Sld3–Sld7 structure, there is a large positive charge area strip on Sld7NTD (Figure 4—figure supplement 4B). Considering that ssARS1 is unwound from dsARS1 by the activated helicase CMG complex formed after loading Cdc45 and GINS, the binding affinity of Sld3–Sld7 may provide an advantage for the dissociation of Sld7–Sld3 from the CMG complex.

Discussion

As a central regulator of helicase CMG formation, Sld3 has attracted interest in studies aiming to understand the initiation of DNA replication. Owing to the lack of structural information on Sld3 complexed with Cdc45 or MCM, how Sld3 regulates the formation of activated helicase CMG with other factors remains unknown. Here, we present the structure of the Sld3CBD–Cdc45 complex and particle size of the Sld7–Sld3–Cdc45 complex to examine the molecular mechanisms underlying CMG formation.

Sld3 exhibits high conservation across eukaryotes, whereas its functional ortholog in metazoans, Treslin (also known as TICRR), has a distinct size and sequence, except for the Cdc45-binding domain (Sld3CBD). Sequence alignment of Sld3CBD among Sld3 and Treslin revealed that all Cdc45-binding residues in α8 and α9 identified in our study were almost conserved or exhibited conserved changes (Figure 1—figure supplements 5 and 6). This conservation suggests that these regions provide a similar interaction manner between Sld3CBD and Cdc45 in the regulation of metazoan DNA replication. Therefore, we hypothesize that Treslin may load Cdc45 as observed in yeast Sld3 and Sld7.

By structural comparison, we found that Sld3CBD and Cdc45 changed their conformations to bind to each other. The conformational changes in Cdc45 DHHA1 upon binding to Sld3CBD also caused the contact between Cdc45 and Mcm2NTD in the Sld3CBD–Cdc45–MCM–dsDNA and SCMG–dsDNA models, whereas DHHA1 interacted with neither MCM nor GINS in the CMG structure. Taking the structural information together, Sld3 seems to play a guiding role in helping Cdc45 bind to MCM at the right position. Furthermore, Sld3CBDs in each monomer of the Sld3CBD–Cdc45–MCM dimer were located at a distance of more than 230 Å, which is consistent with the results of a particle size analysis of the Sld7–Sld3ΔC–Cdc45 complex off MCM DH in solution. Therefore, we propose that a binding manner of Sld7–Sld3–Cdc45 in a flexible long-shaped dimer Cdc45–Sld3–(Sld7)2–Sld3–Cdc45 off/on MCM DH is advantageous for efficiently recruiting two Cdc45 molecules to an MCM DH, consequently leading to the formation of a pair of CMG helicases.

In the SCMG–dsDNA complex model, Cdc45 bound to Sld3CBD, MCM, and GINS on different sides (with contact surfaces of 6.7, 4.8, and 5.1% of the total Cdc45 surface, respectively). Our structure of Sld3CBD-Cdc45 and models show that these bindings occur at distinct sites on Cdc45, suggesting that Sld3CBD, Cdc45, and GINS could bind to MCM together without steric clash. The competition between Sld3 and GINS for binding to Cdc45 or Cdc45-MCM (by mixing them in vitro) reported by Bruck et al. (Bruck and Kaplan, 2011) may be caused by the conformational change of Cdc45 DHHA1 or the lack of other auxiliary initiation factors, indicating that activated CMG formation requires regulation. In particular, Sld3 and GINS bind to opposite positions of Cdc45 and MCM ring (Mcm2–4–6 vs Sld3 and Mcm5–3–7 vs GINS), suggesting that the GINS-recruitment protein should cross a long distance in an MCM monomer or MCM DH to access the phosphorylation site (T600 and S622) of Sld3. Furthermore, our SCMG–dsDNA model revealed that Sld3CBD on CMG appears to contact an N-terminal helix of Mcm2CTD, while Sld3CTD may extend to bind to Mcm4NTD through interaction with the Mcm2NTD and Mcm6NTD (Figure 4—figure supplement 5). These findings suggest that the Sld3–Sld7 binding to MCM does not interfere with the AAA+ motors' ability to regulate MCM ring dynamics during its opening/closing via the gap between Mcm2CTD and Mcm5CTD (Abid Ali et al., 2017; Yuan et al., 2016; Noguchi et al., 2017; Li et al., 2015). Taking our findings and those of previous studies together, we propose a detailed process for helicase CMG formation from inactive MCM, as depicted in Figure 5A–C: Sld7–Sld3 brings Cdc45 onto MCM as a Sld7–Sld3–Cdc45 dimer (Cdc45–Sld3–[Sld7]2–Sld3–Cdc45), and remains until GINS loading.

Figure 5. Proposal for Cdc45–MCM–GINS (CMG) formation with Sld7–Sld3.

Figure 5.

(A) Phosphorylation of Mcm2,4,6 by DDK after MCM double hexamer (DH) was loaded on double-stranded DNA (dsDNA) at the replication origin. (B) Cdc45 recruitment to MCM DH by Cdc45–Sld3–[Sld7]2–Sld3–Cdc45. (C) After CDK-mediated phosphorylation of Sld3CTD in Cdc45–MCM, Dpb11–Sld2 recruits GINS and polε to Sld7–Sld3-Cdc45–MCM to form an active helicase CMG. (D) Unwinding of dsDNA by CMG with MCM DH separation and MCM ring opening. Sld3 and other factors are released upon binding to single-stranded DNA (ssDNA). (E) Each CMG unwinds the dsDNA in two directions, initiating DNA replication.

The following inquiry concerns the dissociation of Sld3 and other factors. Interestingly, the mutant analysis demonstrates that disrupting a single binding site between Sld3CBD and Cdc45 suffices to dissociate Sld3CBD and Cdc45, indicating that a functionally critical binding between Sld3CBD and Cdc45 can be broken easily. Furthermore, our binding analysis of ssARS1 fragments to Sld3CBD, Sld3CBD–Cdc45, Sld7–Sld3ΔC–Cdc45 and Sld7–Sld3ΔC showed the sequence specificity to ssARS1-2 and ssARS1-5 fragments, not others. Considering that ssARS1-2 and ssARS1-5 are on both sides of MCM DH-bound dsDNA at replication origin (Chang et al., 2011), the origin unwinding by CMG generates ssDNA and further sequesters the Sld7-Sld3 complex onto ssDNA to remove Sld7-Sld3 from CMG. As a bridge protein, Sld3 recruits Cdc45 to MCM, and its next phosphorylated state regulates the subsequent recruitment of GINS loading with Dpb11–Sld2 (Muramatsu et al., 2010). Thus, the release of Sld3 and Sld7 from CMG could be associated with unwound ssARS1 and may also be related to the dissociation of Dpb11–Sld2 from CMG (Figure 5D and E; Lewis et al., 2022; Douglas et al., 2018). Furthermore, our proposals require a visualization of the Sld3–Sld7–Cdc45–MCM complex structure during GINS recruitment to establish the complete CMG formation process.

In conclusion, our structural and biochemical studies of Sld3CBD–Cdc45 revealed a detailed process of CMG formation and the subsequent ssDNA-mediated release of the central regulator Sld3 with other factors, leading to a deeper understanding of the initiation mechanism of DNA replication.

Materials and methods

Preparation of proteins

The C-terminal His-tagged Sld3CBD of S. cerevisiae was expressed in Escherichia coli and prepared as previously described (Itou et al., 2014). For co-expression of S. cerevisiae Sld3CBD (S148–K430) and Cdc45 (M1-L650) (Sld3CBD–Cdc45) in E. coli, the Sld3CBD DNA fragment containing the His6-tag (LEHHHHHH) at the C-terminus and the Cdc45 DNA fragment were cloned in the co-overexpression vector pETDuet-1 between the NcoI and SalI restriction sites and the NdeI and XhoI restriction sites, respectively. The primer sequences for Sld3CBD–Cdc45 are listed in Supplementary file 1.

To confirm the interactions obtained from the Sld3CBD–Cdc45 structure, we constructed four types of single or multi-mutants for Sld3CBD (Sld3-3S: I352S/I355S/L356S, Sld3-3E: I352E/I355E/L356E, Sld3-2R: D344R/D348R, and Sld3-Y: I352Y), and three types of single or multi-mutants for Cdc45 (Cdc45-IIIS: L522S/L527S/V529S, Cdc45-IIIE: L522E/L527E/V529E, Cdc45-IIS: L637S/L641S, Cdc45-IIE: L637E/L641E, and Cdc45-A: R523A) using the Quick Change site-directed mutagenesis method and the inverse PCR method with pETDuet-1–Sld3CBD–Cdc45 as template DNA. The primer sequences for the mutant strains are listed in Supplementary file 1.

As S. cerevisiae Sld7–Sld3–Cdc45 could not be co-overexpressed in E. coli, we attempted to clone it from several other fungal sources. As a result, complex of Sld7 (M1-T268), Sld3ΔC (M1-K430, truncated C-terminal domain), and Cdc45 (M1-I666) from the budding yeast Kluyveromyces marxianus, which belongs to the same family as S. cerevisiae (Sld7–Sld3ΔC–Cdc45) was obtained. Sld7, Sld3 and Cdc45 have sequence conservation with similar structures (RMSD = 0.356, 1.392, and 0.891 for Cα atoms of Sld7CTD, Sld7NTD-Sld3NTD, and Sld3CBD-Cdc45) predicted by the Alphafold3 (Abramson et al., 2024). Sld7–Sld3ΔC–Cdc45 was cloned into pETDuet-1 with a His6-tag (LEHHHHHH) at the C-terminus of Sld3ΔC. The primer sequences for Sld7–Sld3ΔC and Sld7–Sld3ΔC–Cdc45 are listed in Supplementary file 1. As Cdc45 mutants can lose the ability to bind to Sld3, we overexpress Sld7–Sld3ΔC by using multi-mutants of Cdc45 (Cdc45-IIS) in Sld7–Sld3ΔC–Cdc45. The Ser-substitution residues (L654S/L658S) of Cdc45-IIS from K. marxianus were selected based on sequence conservation. We constructed mutant Sld7–Sld3ΔC–Cdc45-IIS using the Quick Change site-directed mutagenesis method and the inverse PCR method with pETDuet-1–Sld7–Sld3ΔC–Cdc45 as the template DNA. The primer sequences for the mutant strains are listed in Supplementary file 1.

To overexpress Sld3CBD, Sld3CBD–Cdc45, Sld3CBD–Cdc45 mutants, Sld7–Sld3ΔC–Cdc45 and Sld7–Sld3ΔC, the vector of pET26Sld3CBD, pETDuet-1-Sld3CBD–Cdc45, pETDuet-1-Sld3CBD–Cdc45 mutants, pETDuet-1-Sld7–Sld3ΔC–Cdc45 or pETDuet-1-Sld7–Sld3ΔC was transformed into E. coli strain BL21 (DE3) through electroporation, followed by preculturing in 5 ml of Luria–Bertani medium containing 100 μg/mL ampicillin at 310 K overnight. The culture was then transferred to 3 L Luria–Bertani medium and grown until the OD600 reached 0.6. After cooling the culture for 30 min on ice, overexpression of each sample was induced by the addition of isopropyl-β-D-1-thiogalactopyranoside to a final concentration of 0.5 mM, and then cells were grown for an additional 12 hr at 293 K. Cells were harvested by centrifugation at 4000 g for 20 min at 283 K and then resuspended in a buffer containing 20 mM Tris-HCl pH 7.5, 300 mM NaCl, 10% glycerol, 0.1 mg/ml DNase, and 1× protease-inhibitor cocktail (cOmplete EDTA-free; Roche, Basel, Switzerland).

The harvested cells were crushed through sonication and centrifuged at 40,000 g for 30 min at 283 K. After filtration through a 0.45 µm filter (Sigma-Aldrich/Merck Millipore, Burlington, MA, USA), the supernatant was then loaded onto the HisTrap HP column equilibrated with buffer A [20 mM Tris-HCl, pH 7.5, 300 mM NaCl, 10% glycerol] and the column was washed with buffer A. The His-tagged target protein was eluted with imidazole at 20% (100 mM), 30% (150 mM), and 50% (250 mM), followed by a linear gradient of 250–500 mM imidazole in buffer B [20 mM Tris-HCl, pH 7.5, 300 mM NaCl, 10% glycerol, 500 mM imidazole]. We analyzed the fractions using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Except for mutants of Sld3CBD–Cdc45, the pooled fractions were then purified through size-exclusion chromatography with a buffer A-equilibrated Superdex 200 16/60 column (GE HealthCare, Chicago, IL, USA). Protein purity was confirmed through SDS-PAGE. The purified samples were concentrated to 10 mg/ml and stored at 193 K.

Crystallization and diffraction data collection

The crystallization screening of Sld3CBD–Cdc45 was performed at 293 K using the sitting-drop vapor diffusion method. The drop was a mixture of 1.0 µl of a 10 mg/ml protein solution with the equivalent volume of reservoir buffer from the commercial crystallization kits (JCSG core I-IV, classics, classics II, PEGs, PEGsII, and MPD suite from Qiagen, Venlo, the Netherlands). The initial needle- and plate-shaped crystals appeared under eight and one conditions, respectively. After optimizing the conditions by altering the type and concentration of precipitant, the salt reagent, and the pH of the buffer, the best crystals were obtained in a solution of 0.2 M sodium acetate, 0.1 M Bis-Tris propane (pH 6.5: pH 8.5=3:7), 20%(w/v) PEG3500, and a drop containing 2.0 µl of a 10 mg/ml protein solution mixed with the equivalent volume of reservoir buffer.

Diffraction data were collected using a beamline BL-17A at the Photon Factory, Tsukuba, Japan. Before data collection, the crystals were cryoprotected by soaking them in a reservoir buffer supplemented with 5% (v/v) glycerol, and then flash-cooled under a nitrogen gas stream at 100 K. The XDS/XSCALE program was used to index, integrate, scale, and merge the dataset (Kabsch, 2010). Supplementary file 2 summarizes the statistics of data collection and processing.

Structure determination and refinement

The structure of Sld3CBD–Cdc45 was determined using the molecular replacement method with the AutoMR wizard in Phenix (McCoy et al., 2007; Adams et al., 2010). The structures of human Cdc45 (PDBID: 5DGO) (Simon et al., 2016) and Sld3CBD (PDBID: 3WI3) (Itou et al., 2014) were used as search models. Several rounds of refinement were performed using the Phenix_refine program in Phenix, interleaved with manual building and fitting according to the electron density maps of 2Fo-Fc and Fo-Fc using the Coot program (Adams et al., 2010; Emsley and Cowtan, 2004). Supplementary file 2 presents the final refinement statistics and geometry defined by MolProbity (Chen et al., 2010). All structural diagrams were generated using PyMol (Delano, 2002).

Mutant analysis of Sld3 and Cdc45

To analyze the binding sites of Sld3CBD-Cdc45, in conjunction with Cdc45 binding sites to MCM and GINS, we performed a co-express pull-down binding assay. We constructed four variants of Sld3CBD and five variants of Cdc45 according to the binding information from our Sld3CBD–Cdc45 structure. We co-express all mutations of Sld3CBD-Cdc45 (Sld3CBD-C-histag) and load them onto the HisTrap HP column under the same conditions as in [Preparation of proteins]. After extracting the samples through Ni-affinity chromatography, we concentrated each eluted sample to 0.005 mg/mL (by nanodrop A280) and checked the binding status of the mutants using SDS-PAGE. Both Sld3CBD and Cdc45 should be observed in the elution group if they form a complex. The overexpressed level of the Cdc45 was checked by -IPTG and +IPTG.

We performed circular dichroism (CD) spectrometry measurement of Sld3 mutants–Cdc45 to check whether mutations affected the structure. CD spectra were collected using a J-805 spectropolarimeter (JASCO, Tokyo, Japan) in a quartz cell with a path length of 1 mm in an atmosphere of N2 at 298 K. For CD measurements, the samples were dialyzed in a buffer [20 mM Tris-HCl, pH 7.5, 50 mM NaCl] and adjusted to a concentration of 0.5 mg/mL through absorption. CD spectra for the wavelength range of 190–300 nm were obtained by averaging the results of four scans. The results are given in molar ellipticity per residue [θ] mrw (×10−3) vs wavelength/nm (Greenfield, 2006). The secondary structures of each sample were estimated using the K2D3 method (Louis‐Jeune et al., 2012). For wild-type Sld3CBD, we calculated secondary structures from the obtained Sld3CBD–Cdc45 structure.

Growth of mutant cells

The isolation and plasmid shuffling of the temperature-sensitive yeast strain YYK13 (for Sld3 mutant analysis) and Cdc45-35 (for Cdc45 mutant analysis) have been described in a previous study (Kamimura et al., 2001). To investigate Sld3 mutants, strain YYK13 was transformed with the YCplac22 plasmid containing multiple variants of SLD3 mutant genes. The transformants were streaked on SD plates lacking Trp and Leu (SD-Trp, Leu) and SD-Trp, Leu containing 5-fluoroorotic acid (5-FOA-Trp, Leu), and then incubated at 298 K for 3 days. To analyze the Cdc45 mutant, strain Cdc45-35 containing the CDC45 mutant gene was re-transformed with the YEplac195 plasmid containing SLD3 and the YEplac122 plasmid containing SLD7. The transformants were streaked on yeast extract–peptone–dextrose plates and incubated at 298 or 305 K for 3 days.

Modelling of complexes

We constructed the models of Sld3CBD–Cdc45–MCM–dsDNA (Sld3CBD–Cdc45–MCM dimer complexed with dsDNA) and SCMG–dsDNA (SCMG dimer complexed with dsDNA) using a two-step process. First, the structure of the MCM–NTDs in the CMG monomer (PDBID: 3JC6) (Yuan et al., 2016) was superimposed on that of MCM DH complexed with dsDNA (5BK4) (Noguchi et al., 2017) to obtain a dimer of Cdc45–MCM–GINS complexed with dsDNA (Cdc45–MCM–GINS–dsDNA). Next, the models of Sld3CBD–Cdc45–MCM–dsDNA and SCMG–dsDNA were obtained by superimposing Cdc45NTD from Sld3CBD–Cdc45 onto Cdc45–MCM–GINS–dsDNA.

Dynamic light scattering

We estimated the particle size of the Sld7–Sld3ΔC–Cdc45 complex using dynamic light scattering in terms of peak size (Stetefeld et al., 2016). To avoid the effect of concentration, we measured four samples of the Sld7–Sld3ΔC–Cdc45 complex. Each sample was overexpressed independently and purified through size-exclusion chromatography. All samples were concentrated to 10 mg/ml, and stored at 193 K. Before measurement, protein samples were dialyzed in a buffer containing 20 mM Tris-HCl pH 7.5 and 300 mM NaCl and then filtered through a 0.22 μm filter. The pure buffer was measured as a background control and 10 μM lysozyme was measured as a standard control. Dynamic light scattering data were collected and analyzed using a Malvern Zetasizer Nano-ZS instrument (Malvern Panalytical, Malvern, UK) for 0.2–0.5 mg/ml, 500 μl protein samples in a microquartz cuvette (Malvern-ZEN0112). An automatic duration model was used to collect data. The Zetasizer 6.20 was utilized for data analysis from three measurements to estimate the particle size of each sample.

Electrophoretic mobility shift assay for ssDNA binding

Sld3 binds to single strands of DNA (ssARS1-2 and ssARS1-5) (Bruck and Kaplan, 2011). To determine the specificity of the ssDNA binding affinity of Sld3, we conducted an electrophoretic mobility shift assay (EMSA) using non-denaturing PAGE (native-PAGE) (Hellman and Fried, 2007). Given that Cdc45 binds ssDNA with a nonspecific sequence at lengths greater than 60 bases (Bruck and Kaplan, 2013), we designed three fragments of ssDNA 40 bases in length (first half 1–40 bp, second half 41–80 bp, and middle half 21–60 bp) for each ssDNA 80 bp segment. All ssDNA fragments of S. cerevisiae were synthesized by Sigma-Aldrich. The 40 bp dsDNA fragments (dsARS1-34_1:ssARS1-3_1/ssARS1-4_2) were converted by annealing them using the PCR protocol and then checked through polyacrylamide gel electrophoresis. The loaded samples were incubated overnight at 277 K in TMK buffer (20 mM Tris-HCl pH8, 100 mM MgCl2, 200 mM KCl) containing synthesized ssDNA and varying amounts of proteins at ssDNA: protein molecular ratios of 1:0, 1:0.5, 1:1, 1:2, and 0:1 with 20 pM as 1 unit. After incubation, the mixtures were loaded onto a polyacrylamide gel (5% (w/v) acrylamide (39:1), 10% 10 ×running buffer (0.25 M Tris, 1.92 M Glycine), 0.1% Ammonium peroxodisulphate, 0.06% (v/v) TEMED) without denaturing (native-PAGE). EMSA was performed at 10 mA/200 V per gel for 40 min at 277 K in 1× running buffer. After electrophoresis, the reaction products were visualized using Fast Blast DNA stain (Bio-Rad Laboratories, Hercules, CA, USA) (100 × Fast Blast DNA stain diluted by 1× running buffer) or SYBR safe (Sigma-Aldrich, Burlington, MA, USA) (SYBR safe:1 × running buffer = 0.0001:1) to stain the ssDNA and Coomassie Brilliant Blue (G-250) to stain the proteins. We repeated the EMSA experiments three or more times to confirm the readability. All EMSA results were converted into 8-bit images after brightness and contrast normalized, then the background was removed, and the integrated grayscale was calculated using ImageJ (Abràmoff et al., 2004). The results of band-integrated grayscale calculation were performed with a t-test and plotted using GraphPAD Prism (Graphpad Software, San Diego, CA, USA). Considering the functional similarity of ARS1-core, the EMSA of Sld7–Sld3ΔC and Sld7–Sld3ΔC–Cdc45 of K. marxianus used ssDNA fragments of S. cerevisiae.

Acknowledgements

The authors thank Mr. Naofumi Sakurai for his help in the protein purifications. We would like to thank Dr. Nobutaka Shimizu and Dr. Kento Yonezawa for SEC-SAXS experiments, and the beamline staff of the Photon Factory and SPring-8 for collecting X-ray diffraction data (Proposal No. 2016A2562, 2017 A2551, and 2018 A2508)

Funding Statement

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Contributor Information

Hiroyuki Araki, Email: hiaraki@nig.ac.jp.

Min Yao, Email: yao@castor.sci.hokudai.ac.jp.

Akira Shinohara, The University of Osaka, Japan.

Volker Dötsch, Goethe University Frankfurt, Frankfurt am Main, Germany.

Funding Information

This paper was supported by the following grants:

  • Japan Society for the Promotion of Science, KAKENHI Grant-in-aid for Scientific Research(B) 21H01754 to Min Yao.

  • Japan Agency for Medical Research and Development, Platform Project for Supporting Drug Discovery and Life Science Research JP18am0101071 to Min Yao.

  • Japan Agency for Medical Research and Development, Platform Project for Supporting Drug Discovery and Life Science Research JP19am0101083 to Min Yao.

Additional information

Competing interests

No competing interests declared.

Author contributions

Formal analysis, Investigation, Writing – original draft.

Formal analysis, Investigation.

Formal analysis.

Investigation.

Investigation.

Investigation, Writing – review and editing.

Formal analysis.

Conceptualization, Formal analysis, Writing – review and editing.

Conceptualization, Formal analysis, Methodology, Writing – review and editing.

Additional files

Supplementary file 1. Primers used in this study.
elife-101717-supp1.docx (33.7KB, docx)
Supplementary file 2. Statistics of data collection and refinement.
elife-101717-supp2.docx (45.6KB, docx)
MDAR checklist

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Diffraction data and structure have been deposited in PDB under the accession code 8J09.

The following dataset was generated:

Li H, Ishizaka I, Kato K, Sun X, Muramatsu S, Itou H, Ose T, Araki H, Yao M. 2023. Crystal structure of the Sld3 Cdc45-binding-domain, in complex with Cdc45. Worldwide Protein Data Bank.

References

  1. Abid Ali F, Douglas ME, Locke J, Pye VE, Nans A, Diffley JFX, Costa A. Cryo-EM structure of a licensed DNA replication origin. Nature Communications. 2017;8:2241. doi: 10.1038/s41467-017-02389-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Abràmoff MD, Magalhães PJ, Ram SJ. Image processing with ImageJ. Biophotonics International. 2004;11:36–42. [Google Scholar]
  3. Abramson J, Adler J, Dunger J, Evans R, Green T, Pritzel A, Ronneberger O, Willmore L, Ballard AJ, Bambrick J, Bodenstein SW, Evans DA, Hung CC, O’Neill M, Reiman D, Tunyasuvunakool K, Wu Z, Žemgulytė A, Arvaniti E, Beattie C, Bertolli O, Bridgland A, Cherepanov A, Congreve M, Cowen-Rivers AI, Cowie A, Figurnov M, Fuchs FB, Gladman H, Jain R, Khan YA, Low CMR, Perlin K, Potapenko A, Savy P, Singh S, Stecula A, Thillaisundaram A, Tong C, Yakneen S, Zhong ED, Zielinski M, Žídek A, Bapst V, Kohli P, Jaderberg M, Hassabis D, Jumper JM. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature. 2024;630:493–500. doi: 10.1038/s41586-024-07487-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Adams PD, Afonine PV, Bunkóczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallographica. Section D, Biological Crystallography. 2010;66:213–221. doi: 10.1107/S0907444909052925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bochman ML, Bell SP, Schwacha A. Subunit organization of Mcm2-7 and the unequal role of active sites in ATP hydrolysis and viability. Molecular and Cellular Biology. 2008;28:5865–5873. doi: 10.1128/MCB.00161-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bruck I, Kanter DM, Kaplan DL. Enabling association of the GINS protein tetramer with the mini chromosome maintenance (Mcm)2-7 protein complex by phosphorylated Sld2 protein and single-stranded origin DNA. The Journal of Biological Chemistry. 2011;286:36414–36426. doi: 10.1074/jbc.M111.282822. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bruck I, Kaplan DL. Origin single-stranded DNA releases Sld3 protein from the Mcm2-7 complex, allowing the GINS tetramer to bind the Mcm2-7 complex. The Journal of Biological Chemistry. 2011;286:18602–18613. doi: 10.1074/jbc.M111.226332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bruck I, Kaplan DL. Cdc45 protein-single-stranded DNA interaction is important for stalling the helicase during replication stress. The Journal of Biological Chemistry. 2013;288:7550–7563. doi: 10.1074/jbc.M112.440941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chang F, May CD, Hoggard T, Miller J, Fox CA, Weinreich M. High-resolution analysis of four efficient yeast replication origins reveals new insights into the ORC and putative MCM binding elements. Nucleic Acids Research. 2011;39:6523–6535. doi: 10.1093/nar/gkr301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chen VB, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, Richardson DC, Arendall WB. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallographica. Section D, Biological Crystallography. 2010;66:12–21. doi: 10.1107/S0907444909042073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Choi JM, Lim HS, Kim JJ, Song OK, Cho Y. Crystal structure of the human GINS complex. Genes & Development. 2007;21:1316–1321. doi: 10.1101/gad.1548107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Costa A, Ilves I, Tamberg N, Petojevic T, Nogales E, Botchan MR, Berger JM. The structural basis for MCM2–7 helicase activation by GINS and Cdc45. Nature Structural & Molecular Biology. 2011;18:471–477. doi: 10.1038/nsmb.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Costa A, Diffley JFX. The initiation of eukaryotic DNA replication. Annual Review of Biochemistry. 2022;91:107–131. doi: 10.1146/annurev-biochem-072321-110228. [DOI] [PubMed] [Google Scholar]
  14. Cvetkovic MA, Passaretti P, Butryn A, Reynolds-Winczura A, Kingsley G, Skagia A, Fernandez-Cuesta C, Poovathumkadavil D, George R, Chauhan AS, Jhujh SS, Stewart GS, Gambus A, Costa A. The structural mechanism of dimeric DONSON in replicative helicase activation. Molecular Cell. 2023;83:4017–4031. doi: 10.1016/j.molcel.2023.09.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Deegan TD, Yeeles JT, Diffley JF. Phosphopeptide binding by Sld3 links Dbf4-dependent kinase to MCM replicative helicase activation. The EMBO Journal. 2016;35:961–973. doi: 10.15252/embj.201593552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. De Jesús-Kim L, Friedman LJ, Lõoke M, Ramsoomair CK, Gelles J, Bell SP. DDK regulates replication initiation by controlling the multiplicity of Cdc45-GINS binding to Mcm2-7. eLife. 2021;10:e65471. doi: 10.7554/eLife.65471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Delano WL. PyMol: an open‐source molecular graphics tool. CCP4 Newsletter. Protein Crystallography. 2002;40:82–92. [Google Scholar]
  18. Denkiewicz-Kruk M, Chaudhry D, Krasilia A, Jedrychowska M, Fijalkowska IJ, Dmowski M. Effects of CDC45 mutations on DNA replication and genome stability. Biochimica et Biophysica Acta BBA - Molecular Cell Research. 2025;1872:119936. doi: 10.1016/j.bbamcr.2025.119936. [DOI] [PubMed] [Google Scholar]
  19. Dhingra N, Bruck I, Smith S, Ning B, Kaplan DL. Dpb11 protein helps control assembly of the Cdc45·Mcm2-7·GINS replication fork helicase. The Journal of Biological Chemistry. 2015;290:7586–7601. doi: 10.1074/jbc.M115.640383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Douglas ME, Ali FA, Costa A, Diffley JFX. The mechanism of eukaryotic CMG helicase activation. Nature. 2018;555:265–268. doi: 10.1038/nature25787. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallographica. Section D, Biological Crystallography. 2004;60:2126–2132. doi: 10.1107/S0907444904019158. [DOI] [PubMed] [Google Scholar]
  22. Evrin C, Clarke P, Zech J, Lurz R, Sun J, Uhle S, Li H, Stillman B, Speck C. A double-hexameric MCM2-7 complex is loaded onto origin DNA during licensing of eukaryotic DNA replication. PNAS. 2009;106:20240–20245. doi: 10.1073/pnas.0911500106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Frigola J, He J, Kinkelin K, Pye VE, Renault L, Douglas ME, Remus D, Cherepanov P, Costa A, Diffley JFX. Cdt1 stabilizes an open MCM ring for helicase loading. Nature Communications. 2017;8:15720. doi: 10.1038/ncomms15720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Greenfield NJ. Using circular dichroism spectra to estimate protein secondary structure. Nature Protocols. 2006;1:2876–2890. doi: 10.1038/nprot.2006.202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Heller RC, Kang S, Lam WM, Chen S, Chan CS, Bell SP. Eukaryotic origin-dependent DNA replication in vitro reveals sequential action of DDK and S-CDK kinases. Cell. 2011;146:80–91. doi: 10.1016/j.cell.2011.06.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Hellman LM, Fried MG. Electrophoretic mobility shift assay (EMSA) for detecting protein-nucleic acid interactions. Nature Protocols. 2007;2:1849–1861. doi: 10.1038/nprot.2007.249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Itou H, Muramatsu S, Shirakihara Y, Araki H. Crystal structure of the homology domain of the eukaryotic DNA replication proteins Sld3/Treslin. Structure. 2014;22:1341–1347. doi: 10.1016/j.str.2014.07.001. [DOI] [PubMed] [Google Scholar]
  28. Itou H, Shirakihara Y, Araki H. The quaternary structure of the eukaryotic DNA replication proteins Sld7 and Sld3. Acta Crystallographica. Section D, Biological Crystallography. 2015;71:1649–1656. doi: 10.1107/S1399004715010457. [DOI] [PubMed] [Google Scholar]
  29. Kabsch W. Integration, scaling, space-group assignment and post-refinement. Acta Crystallographica. Section D, Biological Crystallography. 2010;66:133–144. doi: 10.1107/S0907444909047374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kamimura Y, Tak YS, Sugino A, Araki H. Sld3, which interacts with Cdc45 (Sld4), functions for chromosomal DNA replication in Saccharomyces cerevisiae. The EMBO Journal. 2001;20:2097–2107. doi: 10.1093/emboj/20.8.2097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Kurniawan F, Shi K, Kurahashi K, Bielinsky AK, Aihara H. Crystal Structure of Entamoeba histolytica Cdc45 suggests a conformational switch that may regulate DNA replication. iScience. 2018;3:102–109. doi: 10.1016/j.isci.2018.04.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Lewis JS, Gross MH, Sousa J, Henrikus SS, Greiwe JF, Nans A, Diffley JFX, Costa A. Mechanism of replication origin melting nucleated by CMG helicase assembly. Nature. 2022;606:1007–1014. doi: 10.1038/s41586-022-04829-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Li N, Zhai Y, Zhang Y, Li W, Yang M, Lei J, Tye BK, Gao N. Structure of the eukaryotic MCM complex at 3.8 Å. Nature. 2015;524:186–191. doi: 10.1038/nature14685. [DOI] [PubMed] [Google Scholar]
  34. Louis‐Jeune C, Andrade‐Navarro MA, Perez‐Iratxeta C. Prediction of protein secondary structure from circular dichroism using theoretically derived spectra. Proteins. 2012;80:374–381. doi: 10.1002/prot.23188. [DOI] [PubMed] [Google Scholar]
  35. Masumoto H, Muramatsu S, Kamimura Y, Araki H. S-Cdk-dependent phosphorylation of Sld2 essential for chromosomal DNA replication in budding yeast. Nature. 2002;415:651–655. doi: 10.1038/nature713. [DOI] [PubMed] [Google Scholar]
  36. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ. Phaser crystallographic software. Journal of Applied Crystallography. 2007;40:658–674. doi: 10.1107/S0021889807021206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Muramatsu S, Hirai K, Tak YS, Kamimura Y, Araki H. CDK-dependent complex formation between replication proteins Dpb11, Sld2, Pol ɛ, and GINS in budding yeast. Genes & Development. 2010;24:602–612. doi: 10.1101/gad.1883410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Nakajima R, Masukata H. SpSld3 is required for loading and maintenance of SpCdc45 on chromatin in DNA replication in fission yeast. Molecular Biology of the Cell. 2002;13:1462–1472. doi: 10.1091/mbc.02-01-0006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Newlon CS, Theis JF. The structure and function of yeast ARS elements. Current Opinion in Genetics & Development. 1993;3:752–758. doi: 10.1016/S0959-437X(05)80094-2. [DOI] [PubMed] [Google Scholar]
  40. Noguchi Y, Yuan Z, Bai L, Schneider S, Zhao G, Stillman B, Speck C, Li H. Cryo-EM structure of Mcm2-7 double hexamer on DNA suggests a lagging-strand DNA extrusion model. PNAS. 2017;114:E9529–E9538. doi: 10.1073/pnas.1712537114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Remus D, Beuron F, Tolun G, Griffith JD, Morris EP, Diffley JFX. Concerted loading of Mcm2-7 double hexamers around DNA during DNA replication origin licensing. Cell. 2009;139:719–730. doi: 10.1016/j.cell.2009.10.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Samel SA, Fernández-Cid A, Sun J, Riera A, Tognetti S, Herrera MC, Li H, Speck C. A unique DNA entry gate serves for regulated loading of the eukaryotic replicative helicase MCM2–7 onto DNA. Genes & Development. 2014;28:1653–1666. doi: 10.1101/gad.242404.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Shimizu N, Yatabe K, Nagatani Y, Saijyo S, Kosuge T, Igarashi N. Software development for analysis of small-angle x-ray scattering data. Proceedings Of The 12th International Conference On Synchrotron Radiation Instrumentation – SRI2015; New York, NY USA. 1741. [DOI] [Google Scholar]
  44. Simon AC, Sannino V, Costanzo V, Pellegrini L. Structure of human Cdc45 and implications for CMG helicase function. Nature Communications. 2016;7:11638. doi: 10.1038/ncomms11638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Stetefeld J, McKenna SA, Patel TR. Dynamic light scattering: a practical guide and applications in biomedical sciences. Biophysical Reviews. 2016;8:409–427. doi: 10.1007/s12551-016-0218-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Szambowska A, Tessmer I, Kursula P, Usskilat C, Prus P, Pospiech H, Grosse F. DNA binding properties of human Cdc45 suggest a function as molecular wedge for DNA unwinding. Nucleic Acids Research. 2014;42:2308–2319. doi: 10.1093/nar/gkt1217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Tanaka S, Umemori T, Hirai K, Muramatsu S, Kamimura Y, Araki H. CDK-dependent phosphorylation of Sld2 and Sld3 initiates DNA replication in budding yeast. Nature. 2007;445:328–332. doi: 10.1038/nature05465. [DOI] [PubMed] [Google Scholar]
  48. Tanaka T, Umemori T, Endo S, Muramatsu S, Kanemaki M, Kamimura Y, Obuse C, Araki H. Sld7, an Sld3-associated protein required for efficient chromosomal DNA replication in budding yeast. The EMBO Journal. 2011;30:2019–2030. doi: 10.1038/emboj.2011.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Tanaka S, Araki H. Helicase activation and establishment of replication forks at chromosomal origins of replication. Cold Spring Harbor Perspectives in Biology. 2013;5:a010371. doi: 10.1101/cshperspect.a010371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Tanaka S, Komeda Y, Umemori T, Kubota Y, Takisawa H, Araki H. Efficient initiation of DNA replication in eukaryotes requires Dpb11/TopBP1-GINS interaction. Molecular and Cellular Biology. 2013;33:2614–2622. doi: 10.1128/MCB.00431-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Ticau S, Friedman LJ, Champasa K, Corrêa IR, Jr, Gelles J, Bell SP. Mechanism and timing of Mcm2–7 ring closure during DNA replication origin licensing. Nature Structural & Molecular Biology. 2017;24:309–315. doi: 10.1038/nsmb.3375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Yonezawa K, Takahashi M, Yatabe K, Nagatani Y, Shimizu N. Software for serial data analysis measured by SEC-SAXS/UV-Vis spectroscopy. AIP Conf. Proc. 2054; 2019. [DOI] [Google Scholar]
  53. Yuan Z, Bai L, Sun J, Georgescu R, Liu J, O’Donnell ME, Li H. Structure of the eukaryotic replicative CMG helicase suggests a pumpjack motion for translocation. Nature Structural & Molecular Biology. 2016;23:217–224. doi: 10.1038/nsmb.3170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Zegerman P, Diffley JFX. Phosphorylation of Sld2 and Sld3 by cyclin-dependent kinases promotes DNA replication in budding yeast. Nature. 2007;445:281–285. doi: 10.1038/nature05432. [DOI] [PubMed] [Google Scholar]
  55. Zhai Y, Cheng E, Wu H, Li N, Yung PYK, Gao N, Tye BK. Open-ringed structure of the Cdt1–Mcm2–7 complex as a precursor of the MCM double hexamer. Nature Structural & Molecular Biology. 2017;24:300–308. doi: 10.1038/nsmb.3374. [DOI] [PubMed] [Google Scholar]

eLife Assessment

Akira Shinohara 1

This valuable paper describes the crystal structure of a complex of the Sld3-Cdc45-binding domain (CBD) with Cdc45, which is essential for the assembly of an active Cdc45-MCM-GINS (CMG) double-hexamer at the replication origin. The structural and biochemical analyses of protein-protein interactions and DNA binding provided solid evidence to support the authors' conclusion. The results shown in the paper are of interest to researchers in DNA replication and genome stability.

Reviewer #1 (Public review):

Anonymous

Summary:

The crystal structure of the Sld3CBD-Cdc45 complex presented by Li et al. is a significant contribution that enhances our understanding of CMG formation during the rate-limiting step of DNA replication initiation. This structure provides crucial insights into the intermediate steps of CMG formation, and the particle analysis and model predictions compellingly describe the mechanism of Cdc45 loading.

Building upon previously known Sld3 and Cdc45 structures, this study offers new perspectives on how Cdc45 is recruited to MCM DH through the Sld3-Sld7 complex. The most notable finding is the structural rearrangement of Sld3CBD upon Cdc45 binding, particularly the α8-helix conformation, which is essential for Cdc45 interaction and may also be relevant to its metazoan counterpart, Treslin. Additionally, the conformational shift in the DHHA1 domain of Cdc45 suggests a potential mechanism for its binding to Mcm2NTD.

Furthermore, the ssDNA-binding experiments involving Sld3 further support a broader functional role in the replication process, beyond its established role in recruiting Cdc45. This adds an intriguing new layer to our understanding of Sld3's activity in the yeast.

Reviewer #2 (Public review):

Anonymous

Summary

The manuscript presents valuable findings, particularly in the crystal structure of the Sld3CBD-Cdc45 interaction and the identification of additional sequences involved in their binding. The modeling of the Sld7-Sld3CBD-CDC45 subcomplex is novel, and the results provide insights into potential conformational changes that occur upon interaction. Although the single-stranded DNA binding data from Sld3 of different species is a minor weakness, the experiments support a model in which the release of Sld3 from the complex may be promoted by its binding to origin single-stranded DNA exposed by the helicase.

Reviewer #3 (Public review):

Anonymous

Summary:

The paper by Li et al. describes the crystal structure of a complex of Sld3-Cdc45-binding domain (CBD) with Cdc45 and a model of the dimer of an Sld3-binding protein, Sld7, with two Sld3-CBD-Cdc45 for the tethering. In addition, the authors showed the genetic analysis of the amino acid substitution of residues of Sld3 in the interface with Cdc45 and biochemical analysis of the protein interaction between Sld3 and Cdc45 as well as DNA binding activity of Sld3 to the single-strand DNAs of the ARS sequence.

eLife. 2025 Sep 8;13:RP101717. doi: 10.7554/eLife.101717.4.sa4

Author response

Hao Li 1, Izumi Ishizaki 2, Koji Kato 3, Xiaomei Sun 4, Sachiko Muramatsu 5, Hiroshi Itou 6, Toyoyuki Ose 7, Hiroyuki Araki 8, Min Yao 9

The following is the authors’ response to the previous reviews

Reviewer #1 (Public review):

Summary:

The crystal structure of the Sld3CBD-Cdc45 complex presented by Li et al. is a significant contribution that enhances our understanding of CMG formation during the rate-limiting step of DNA replication initiation. This structure provides crucial insights into the intermediate steps of CMG formation, and the particle analysis and model predictions compellingly describe the mechanism of Cdc45 loading. Building upon previously known Sld3 and Cdc45 structures, this study offers new perspectives on how Cdc45 is recruited to MCM DH through the Sld3-Sld7 complex. The most notable finding is the structural rearrangement of Sld3CBD upon Cdc45 binding, particularly the α8-helix conformation, which is essential for Cdc45 interaction and may also be relevant to its metazoan counterpart, Treslin. Additionally, the conformational shift in the DHHA1 domain of Cdc45 suggests a potential mechanism for its binding to Mcm2NTD. Furthermore, Sld3's ssDNA-binding experiments provide evidence of its novel functions in the DNA replication process in yeast, expanding our understanding of its role beyond Cdc45 recruitment.

Strengths:

The manuscript is generally well-written, with a precise structural analysis and a solid methodological section that will significantly advance future studies in the field. The predictions based on structural alignments are intriguing and provide a new direction for exploring CMG formation, potentially shaping the future of DNA replication research. This research also opens up several new opportunities to utilize structural biology to unravel the molecular details of the model presented in the paper.

Weaknesses:

The main weakness of the manuscript lies in the lack of detailed structural validation for the proposed Sld3-Sld7-Cdc45 model, and its CMG bound models, which could be done in the future using advanced structural biology techniques such as single particle cryo-electron microscopy. It would also be interesting to explore how Sld7 interacts with the MCM helicase, and this would help to build a detailed long-flexible model of Sld3-Sld7-Cdc45 binding to MCM DH and to show where Sld7 will lie on the structure. This will help us to understand how Sld7 functions in the complex. Also, future experiments would be needed to understand the molecular details of how Sld3 and Sld7 release from CMG is associated with ssARS1 binding.

The proposals based on this study provide new knowledge of the CMG formation process. We agree that our Sld3-Sld7-Cdc45 model will be further confirmed by cryo-EM. We improved our ssARS1-binding assay and quantified data (See the response to Recommendations for the authors of #3 review).

Reviewer #2 (Public review):

Summary

The manuscript presents valuable findings, particularly in the crystal structure of the Sld3CBD-Cdc45 interaction and the identification of additional sequences involved in their binding. The modeling of the Sld7-Sld3CBD-CDC45 subcomplex is novel, and the results provide insights into potential conformational changes that occur upon interaction. Although the single-stranded DNA binding data from Sld3 of different species is a minor weakness, the experiments support a model in which the release of Sld3 from the complex may be promoted by its binding to origin single-stranded DNA exposed by the helicase.

Strengths

The Sld3CBD-Cdc45 structure is a novel contribution, revealing critical residues involved in the interaction.

The model structures generated from the crystal data are well presented and provide valuable insights into the interaction sequences between Sld3 and Cdc45.

The experiments testing the requirements for interaction sequences are thorough and conducted well, with clear figures supporting the conclusions.

The conformational changes observed in Sld3 and Cdc45 upon binding are interesting and enhance our understanding of the interaction.

The modeling of the Sld7-Sld3CBD-CDC45 subcomplex is a new and valuable addition to the field.

The proposed model of Sld3 release from the complex through binding to single stranded DNA at the origin is intriguing.

Weaknesses

The section on the binding of Sld3 complexes to origin single-stranded DNA is somewhat weakened by the use of Sld3 proteins from different species. The comparisons between Sld3-CBD, Sld3CBD-Cdc45, and Sld7-Sld3CBD-Cdc45 involve complexes from different species, limiting the comparisons' value.

Although the study reveals that Sld3 binds to different residues of Cdc45 than those previously shown to bind Mcm or GINS, the data in the paper do not shed any additional light on how GINS and Sld3 binding to Cdc45 or Mcms. would affect each other. Other previous research has suggested that the binding of GINS and Sld3 to Mcm or Cdc45 may be mutually exclusive. The authors acknowledge that a structural investigation of Sld3, Sld7, Cdc45, and MCM during the stage of GINS recruitment will be a significant goal for future research.

We agree that it is better to use all samples from a source; however, due to limitations in protein expression, we used Sld7-Sld3CBD-Cdc45 from a different source. The two sources used in this study belong to the same family, and the proteins Sld7, Sld3 and Cdc45 share sequence conservation with similar structures predicted by Alphafold3 (RMSD = 0.356, 1.392, and 0.891 for Ca atoms of Sld7CTD, Sld7NTD-Sld3NTD, and Sld3CBD-Cdc45). Such similarity in source and proteins allows us to do the comparison. We also mentioned that a cryo-EM study of Sld3-Sld7-Cdc45-MCM and Sld3-Sld7-CMG structures will be a significant goal for future research in our manuscript.

Reviewer #3 (Public review):

Summary:

The paper by Li et al. describes the crystal structure of a complex of Sld3-Cdc45-binding domain (CBD) with Cdc45 and a model of the dimer of an Sld3-binding protein, Sld7, with two Sld3-CBD-Cdc45 for the tethering. In addition, the authors showed the genetic analysis of the amino acid substitution of residues of Sld3 in the interface with Cdc45 and biochemical analysis of the protein interaction between Sld3 and Cdc45 as well as DNA binding activity of Sld3 to the single-strand DNAs of the ARS sequence.

Strengths:

The authors provided a nice model of an intermediate step in the assembly of an active Cdc45-MCM-GINS (CMG) double hexamers at the replication origin, which is mediated by the Sld3-Sld7 complex. The dimer of the Sld3-Sld7 complexes tethers two MCM hexamers together for the recruitment of GINS-Pol epsilon on the replication origin.

Weaknesses:

The biochemical analysis should be carefully evaluated with more quantitative ways to strengthen the authors' conclusion even in the revised version.

In this revision, we improved our ssARS1-binding assay in more quantitative ways (See the response to Recommendations for the authors).

Reviewer #1 (Recommendations for the authors):

I thank the authors for all their replies to my previous questions and for doing all the necessary corrections. I am satisfied with most of their replies, however, upon second reading I have a few more suggestions which could help to improve the manuscript further and make an impact in the field. My comments are listed below.

(1) In general, the manuscript is well structured, but I feel that it requires professional English correction. In many places it was difficult to understand the sentences and I had to read it several times to understand it. Also, very long sentences should be avoided. The flow should be easy to read and understand, and that is why I feel it requires professional English correction.

Following the comment, we checked English carefully and shortened the very long sentences.

(2) Page 5, line 103, please include molecule after the word complex to make it like- "Only one complex molecule exists within an asymmetric unit."

We revised this sentence (P5/L103).

(3) Line 113- more than the N-terminal half of the protruding long helix α7 113 was disordered in the Sld3CBD-Cdc45 complex. This sentence is not clear. What does it mean more than the N-terminal half? Please rewrite it.

We revised this sentence to give the corresponding residue number “(D219–H231)” (P5/L114).

(4) Page 5, result 2- Conformation changes in Sld3CBD and Cdc45 for binding each other, this section may require a little restructuring. Line 130-131- "Therefore, the helix α8CTP seems to be an intrinsically disordered segment when Sld3 alone but 130 folds into a helix coupled to the binding partner Cdc45 in the Sld3CBD-Cdc45 complex." This statement is the crux of the structural finding and therefore, I feel it should move after the first sentence.

Thank you for your comments. We rewrote this part (P5/L128-131).

(5) Line 121-122: Compared to the isolated form (PDBIDs: 5DGO 121 for huCdc45 [31] and 6CC2 for EhCdc45 [33]) and the CMG form (PDBID: 3JC6). Write it in the same format. Make 6CC2 in bracket like other PDB IDs. Restructure this sentence.

We revised this sentence (P5/122-123).

(6) Line 127-129: This sentence is also not very clear.

We revised this sentence together with above No (4). (P5/L128-131)

(7) In my question 4- "Can authors add a supplementary figure showing the probability of disordernes..."., I meant to use a disorder prediction tool like IUPred for the protein sequences and show that α8 is predicted to be a disordered upon sequence analysis. This will help to show the inherent property of α8 helix, and it could add up to the understanding that a disordered region is being structured in the complex structure.

The structures showed that α8CTP is stabilized by binding with Cdc45, but disordered in Sld3CBD alone, indicating that this part is flexible, like an intrinsically disordered segment. We have deposited the structure to PDB, so predictions like IUPred cannot show meaningful information.

(8) Question 9 regarding Supplementary Figure 8- Please include your statement in the figure legend - "WT Sld3CBD was prepared in a complex with Cdc45, while the mutants of Sld3CBD existed alone, we calculated the elements of secondary structure from the crystal structure of Sld3CBD-Cdc45. The concentration of samples was controlled to the same level for CD measurement."

Following the comment, we optimized the figure legend of Supplementary Figure 8.

(9) Question 13- I understand that negative staining and SEC-SAXS experiments could be very tricky for such protein complexes, which have very long loops and are flexible. Did authors try a GraFix cross-linking before doing the negative staining TEM? If it is not being tried, then it might be a good idea to try it and it may help to get much cleaner particles and easier class averaging. Although I completely understand the technical challenges the authors describe and I agree with them, I still feel that one good experiment that shows this dimer model would be very helpful to strengthen the claim. I am concerned because if people start using a similar DLS experiment to calculate intermolecular distances, citing your paper, in many cases it might be a wrong interpretation. In case the negative staining still does not work, at least discuss your technical challenges in the discussion section and mention that SEC-SAXS showed a similar length of the complex and show the Guinier plot and Porod plots in the supplementary data.

We believe that DLS is one of the methods for analyzing the single particle size. Of course, the confirmation by multiple methods will give compelling evidence. Following the comment, we added SEC-SAXS data in the [Results] (P7/L194-196) (Cdc45 recruitment to MCM DH by Sld3 with partner Sld7) and Supplementary Figure 11. The Sld7-Sld3-Cdc45 forms a flexible, long shape. Each binding domain is rigid but linked by the long loops. The flexibility problems are caused by the long loop linkers, but not by binding. So, we did not try to use the cross-linking method for analysis experiments.

(10) Page 8, line 221- litter sequence specificity: Correct the word "litter" with little. Also, the word shaped is written as sharped at a few places in the manuscript. Please correct it.

We apologize for making such mistakes. We have modified these words.

(11) Page 9, line 237-238: Would it be possible to add a lane showing Sld7 binding to the ssDNA in figure 4. I recommend showing this to understand the ssDNA binding affinity of Sld7 by itself and it will also help us to compare when it is in complex with Sld3.

Considering that Sld7 on CMG is always a complex with Sld3, the ssDNA binding affinity should use the Sld3-Sld7 complex. Additionally, we attempted to overexpress Sld7, but could not obtain the target protein.

Reviewer #2 (Recommendations for the authors):

Thank you for the improved manuscript. The following sentence is unclear: "Cdc45 binds tighter to long ssDNA (>60 bases) with a litter sequence specificity".

We apologize for making such a mistake. We modified “litter” to “little”.

I found it challenging to understand which species were used while reading the results section and figure legends. I recommend that the authors revise the text in both the results and figure legends to clearly indicate when proteins from different species are being compared. Additionally, it would be valuable to explicitly acknowledge this limitation in the text.

Following the comment, we added a description for using different species in results (P8/L224-225) and figure legends (Supplementary Figure 14). We added more information in the Methods to explain why we used two species for preparing proteins.

Reviewer #3 (Recommendations for the authors):

Major points:

(1) The current title is not appropriate for the general readers. At least, DNA replication or DNA replication initiation should be added and abbreviations such as CBD should be avoided.

Following the comment, we added “DNA replication” into the title. Regarding “CBD”, since the full name of “Cdc45 binding domain” is too long, we continue to use Sld3CBD.

(2) As in my previous review, I asked for quantification of the EMSA assay shown in Figure 4 and Supplemental Figures 13 and 14. Since some signals of the bands are very weak, it is hard to conclude something. Given different protein concentrations used in the experiment, the authors should provide any kinds of value. For example, Sld3CBD-CDC45 shows weaker DNA binding than Sld3CBD alone (line 231). Is this true (or reproducible)? It is hard to conclude without any quantification.

We have repeated the EMSA assay four or more times with different rods of overexpression, purification and DNA synthesis, indicating that the EMSA assay is reproducible. In this revision, we changed the DNA stain and adjusted the ratio between the protein and ssDNA with increasing concentrations. The smeared bands of ssDNA with Sld7–Sld3ΔC–Cdc45 or Sld7–Sld3ΔC exhibit enhanced discernibility, and the ssDNA bands are intense enough for grayscale calculations (Figure 4 in the second revised version). We used a series of t-tests to confirm a significantly ssDNA residual level between Sld3CBD–Cdc45 to Sld3CBD, Sld7–Sld3ΔC–Cdc45, and Sld7–Sld3ΔCS (t-test, ****: P<0.0001). We also carefully controlled the sample amount in the EMAS assay and described it in the [Methods].

Moreover, in this EMSA assay (in Figure 4), the authors suggest that the disappearance of ssDNA bands corresponds with the binding of the protein to the DNA. However, it is also possible that the DNA is degraded. It is very important to show the band of protein-DNA complexes on the gel (a whole gel, not the parts of the gel shown in Figure). Why did the authors use this "insensitive" assay using SyberGreen, not radio-labelled ssDNA?

In this revision, we added a negative control of no ssDNA-binding by using ssARS1-3_3 for all protein samples (Sld3CBD, Sld3CBD–Cdc45, Sld7–Sld3ΔC–Cdc45 and Sld7–Sld3ΔC), which were the same rod of expression and purification for bound to ssARS1s (ssARS1-2 and ssARS1-5) (Figure 4), showing that the disappearance of ssDNA bands is caused by binding to proteins, not degradation. Moreover, this time, by changing the DNA stain and increasing the concentration of the samples, the smeared ssDNA bands exhibit enhanced discernibility in the high molecular weight regions when mixed with Sld7–Sld3ΔC–Cdc45 or Sld7–Sld3ΔC, whereas no bands appeared in the NC (ssARS1-3_1). The positions of smeared ssDNA bonds correspond to those of protein in the protein-stain pages, indicating that ssARS1 were complexed with proteins. Following the comment, we show all bands on the gel in Figure 4 and Supplementary Figure 14. Compared to Sld7–Sld3ΔC–Cdc45 or Sld7–Sld3ΔC, Sld3CBD and ssDNA bonds could not be observed because the pI value of Sld3CBD, which affects the entry of the samples into the gel.

We agree that using radio-labelled ssDNA can obtain a sensitive binding assay. However, current laboratory constraints did not allow us to use radio-labelled ssDNA. Furthermore, considering the characteristics of our target proteins, Sld3CBD, Sld3CBD–Cdc45, Sld7–Sld3ΔC–Cdc45, and Sld7–Sld3ΔC, we planned to perform the binding assay in a more natural state without any modifications, labelling or linkers. Additionally, we have attempted to use ITC experiments but failed in the measurements. Presumably, the conformational flexibility of Sld7-Sld3-Cdc45 and Sld7-Sld3 caused a thermodynamic anomaly.

Minor points:

(1) Line 215, 80b: This should be "80 nucleotides(nt)". Throughout the text, nucleotides is better than base to show the length of ssDNAs.

Thank you for your comments. We modified these words throughout the text.

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Data Citations

    1. Li H, Ishizaka I, Kato K, Sun X, Muramatsu S, Itou H, Ose T, Araki H, Yao M. 2023. Crystal structure of the Sld3 Cdc45-binding-domain, in complex with Cdc45. Worldwide Protein Data Bank. [DOI]

    Supplementary Materials

    Figure 1—figure supplement 2—source data 1. PDF file containing original SDS-PAGE for Figure 1—figure supplement 2, indicating the relevant bands and treatments.
    Figure 1—figure supplement 2—source data 2. Original files for SDS-PAGE displayed in Figure 1—figure supplement 2.
    Figure 2—source data 1. PDF file containing original SDS-PAGE for Figure2, indicating the relevant bands and treatments.
    Figure 2—source data 2. Original files for SDS-PAGE displayed in Figure2.
    Figure 2—figure supplement 3—source data 1. PDF file containing original SDS-PAGE for Figure 2—figure supplement 3, indicating the relevant bands and treatments.
    Figure 2—figure supplement 3—source data 2. Original files for SDS-PAGE displayed in Figure 2—figure supplement 3.
    Figure 4—source data 1. PDF file containing original native-PAGE for Figure 4, indicating the relevant bands and treatments.
    Figure 4—source data 2. Original files for native-PAGE displayed in Figure 4.
    Figure 4—figure supplement 2—source data 1. PDF file containing original native-PAGE for Figure 4—figure supplement 2, indicating the relevant bands and treatments.
    Figure 4—figure supplement 2—source data 2. Original files for native-PAGE displayed in Figure 4—figure supplement 2.
    Figure 4—figure supplement 3—source data 1. PDF file containing original native-PAGE for Figure 4—figure supplement 3, indicating the relevant bands and treatments.
    Figure 4—figure supplement 3—source data 2. Original files for native-PAGE displayed in Figure 4—figure supplement 3.
    Supplementary file 1. Primers used in this study.
    elife-101717-supp1.docx (33.7KB, docx)
    Supplementary file 2. Statistics of data collection and refinement.
    elife-101717-supp2.docx (45.6KB, docx)
    MDAR checklist

    Data Availability Statement

    All data generated or analysed during this study are included in the manuscript and supporting files. Diffraction data and structure have been deposited in PDB under the accession code 8J09.

    The following dataset was generated:

    Li H, Ishizaka I, Kato K, Sun X, Muramatsu S, Itou H, Ose T, Araki H, Yao M. 2023. Crystal structure of the Sld3 Cdc45-binding-domain, in complex with Cdc45. Worldwide Protein Data Bank.


    Articles from eLife are provided here courtesy of eLife Sciences Publications, Ltd

    RESOURCES